The present technology relates generally to implantable heart valve devices. In particular, several embodiments are directed to mitral valve devices for percutaneous repair of native mitral valves and associated systems and methods for repair and/or replacement of native mitral valves.
Conditions affecting the proper functioning of the mitral valve include, for example, mitral valve regurgitation, mitral valve prolapse and mitral valve stenosis. Mitral valve regurgitation is a disorder of the heart in which the leaflets of the mitral valve fail to coapt into apposition at peak systolic contraction pressures such that blood leaks abnormally from the left ventricle into the left atrium. There are a number of structural factors that may affect the proper closure of the mitral valve leaflets.
One structural factor that causes the mitral valve leaflet to separate is dilation of the heart muscle.
Another structural factor that can cause abnormal backflow is compromised papillary muscle function due to ischemia or other conditions. As the left ventricle contracts during systole, the affected papillary muscles do not contract sufficiently to effect proper closure of the valve. This in turn can lead to mitral valve regurgitation.
Treatment for mitral valve regurgitation has typically involved the application of diuretics and/or vasodilators to reduce the amount of blood flowing back into the left atrium. Other procedures have involved surgical approaches (open and intravascular) for either the repair or replacement of the valve. Replacement surgery, either done through large open thoracotomies or less invasively through a percutaneous approach, can be effective, but there are compromises of implanting a prosthetic valve. For example, prosthetic mechanical valves require a lifetime of anticoagulation therapy and risks associated with stroke or bleeding. Additionally, prosthetic tissue valves have a finite lifetime, eventually wearing out, for example, over twelve or fifteen years. Therefore, valve replacement surgeries have several shortcomings.
Mitral valve replacement also poses unique anatomical obstacles that render percutaneous mitral valve replacement significantly more challenging than other valve replacement procedures, such as aortic valve replacement. First, aortic valves are relatively symmetric and uniform, but in contrast the mitral valve annulus has a non-circular D-shape or kidney-like shape, with a non-planar, saddle-like geometry often lacking symmetry. Such unpredictability makes it difficult to design a mitral valve prosthesis having that properly conforms to the mitral annulus. Lack of a snug fit between the prosthesis and the native leaflets and/or annulus may leave gaps therein that allows backflow of blood through these gaps. Placement of a cylindrical valve prosthesis, for example, may leave gaps in commissural regions of the native valve that cause perivalvular leaks in those regions. Thus, the anatomy of mitral valves increases the difficulty of mitral valve replacement procedures and devices.
In addition to its irregular, unpredictable shape, which changes size over the course of each heartbeat, the mitral valve annulus lacks radial support from surrounding tissue. The aortic valve, for example, is completely surrounded by fibro-elastic tissue that provides good support for anchoring a prosthetic valve at a native aortic valve. The mitral valve, on the other hand, is bound by muscular tissue on the outer wall only. The inner wall of the mitral valve is bound by a thin vessel wall separating the mitral valve annulus from the inferior portion of the aortic outflow tract. As a result, significant radial forces on the mitral annulus, such as those imparted by an expanding stent prostheses, could lead to impairment of the inferior portion of the aortic tract.
Typical mitral valve repair approaches have involved cinching or resecting portions of the dilated annulus. Cinching of the annulus has been accomplished by implanting annular or peri-annular rings that are generally secured to the annulus or surrounding tissue. Other repair procedures have also involved suturing or clipping of the valve leaflets into partial apposition with one another. For example, the Evalve (Abbott Vascular) MitraClip® clips the two mitral valve leaflets together in the region where the leaflets fail to coapt to thereby reduce or eliminate regurgitation. Mitral valve repair surgery has proven effective, and especially for patients with degenerative disease. Repair surgery typically involves resecting and sewing portions of the valve leaflets to optimize their shape and repairing any torn chordae tendineae, and such surgeries usually include placement of an annuloplasty ring to shrink the overall circumference of the annulus in a manner that reduces the anterior-posterior dimension of the annulus.
Efforts to develop technologies for percutaneous mitral annuloplasty that avoid the trauma, complications, and recovery process associated with surgery, have led to devices and methods for cinching the annulus via the coronary sinus, or cinching the annulus via implantation of screws or anchors connected by a tensioned suture or wire. In operation, the tensioned wire draws the anchors closer to each other to cinch (i.e., pull) areas of the annulus closer together. Additional techniques proposed previously include implanting paired anchors on the anterior and posterior areas of the annulus and pulling them together, and using RF energy to shrink the annular tissue among other approaches.
However, all of these percutaneous annuloplasty approaches have eluded meaningful clinical or commercial success to date, at least partly due to the forces required to change the shape of the native annulus, which is relatively stiff and is subject to significant loads due to ventricular pressure. Furthermore, many of the surgical repair procedures are highly dependent upon the skill of the cardiac surgeon where poorly or inaccurately placed sutures may affect the success of procedures. Overall, many mitral valve repair and replacement procedures have limited durability due to improper sizing or valve wear.
Given the difficulties associated with current procedures, there remains the need for simple, effective, and less invasive devices and methods for treating dysfunctional heart valves, for example, in patients suffering functional mitral valve disease.
At least some embodiments are directed to a method of repairing a native mitral valve having an anterior leaflet and a posterior leaflet between a left atrium and a left ventricle. A repair device having a support can be implanted under the posterior leaflet. The support can be pressed against a portion of an underside of the posterior leaflet and thereby push at least a portion of the posterior leaflet toward the anterior leaflet.
In some embodiments, a method of repairing a native mitral valve having an anterior leaflet and a posterior leaflet between a left atrium and a left ventricle includes positioning a repair device in the left ventricle under the posterior leaflet and between a wall of the left ventricle and chordae tendineae. The repair device can engage an underside of the posterior leaflet such that a portion of the posterior leaflet moves toward the anterior leaflet. In some embodiments, the repair device can further include an appendage extending (e.g., hanging) down beyond an edge of the posterior leaflet and extending that leaflet closer to the anterior leaflet.
At least some embodiments are directed to a method for repairing a native valve of a patient and includes positioning a heart valve repair device in a subannular position behind at least one leaflet connected to chordae tendineae. The repair device has a support in an unexpanded configuration. The support in the subannular position is expanded such that the support engages an interior surface of a heart wall and a downstream-facing surface of the leaflet. The repair device is configured to reposition the leaflet into an at least partially closed position and brace the leaflet to affect native valve function. In some embodiments, the repair device is configured to improve function of the native valve by bracing the leaflet.
In some embodiments, a repair device for repairing a native mitral valve having an anterior leaflet and a posterior leaflet between a left atrium and a left ventricle comprises a support having (a) a contracted configuration in which the support is sized to be inserted under the posterior leaflet between a wall of the left ventricle and chordae tendineae and (b) an extended configuration in which the support projects anteriorly with respect to a posterior wall of the left ventricle by a distance sufficient to position at least a portion of the posterior leaflet toward the anterior leaflet sufficiently to improve coaptation of the posterior and anterior leaflets.
In some embodiments, a heart valve repair device to treat a native valve of a patient comprises a support implantable in a subannular position relative to the native valve. The support can be configured to engage an interior surface of a heart wall and an outward-facing surface of a leaflet of the native valve in the subannular position such that the support repositions the leaflet into a desired position (e.g., at least partially closed position).
In further embodiments, a heart valve repair device to treat a native valve of a patient comprises a frame have a first end configured to be placed at least proximate a first commissure of the native valve, a second end configured to be placed at least proximate a second commissure of the native valve, and a curved region between the first and second ends. The curved region of the frame is configured to engage a backside of a leaflet of the native heart valve so as to reposition the leaflet such that the leaflet at least partially coapts with an adjacent leaflet of the native valve.
In some embodiments, a system to treat a native valve of a patient comprises a prosthetic valve repair device implantable in a subannular position relative to the native valve. The repair device includes a support configured to engage an interior surface of a heart wall and an outward-facing surface of a leaflet of the native valve in a subannular position of the native valve. The support is configured to change an effective annulus shape and/or an effective annulus cross-sectional dimension when the device is in a deployed configuration. In certain embodiments, the system further includes a prosthetic valve having a radially expandable support structure with a lumen and a valve in the lumen and coupled to the support structure. The radially expandable support structure is configured to be deployed within the native valve when the prosthetic valve repair device is implanted in the subannular position and supported within the changed annulus shape or changed annulus cross-sectional dimension.
At least some embodiments are directed to a valve repair device that comprises means for supporting a posterior leaflet. The means for supporting the posterior leaflet has contracted configuration for insertion under the posterior leaflet between a wall of the left ventricle and chordae tendineae and an extended configuration for projecting anteriorly with respect to a posterior wall of the left ventricle. In one embodiment, the means for supporting extends a distance sufficient to position at least a portion of the posterior leaflet toward the anterior leaflet to affect coaptation of the posterior and anterior leaflets. In one embodiment, the means for supporting includes one or more extensions units expandable using one or more filler materials. The means for supporting can further include an elongated spine coupled to the extension unit(s).
Many aspects of the present disclosure can be better understood with reference to the following drawings. The components in the drawings are not necessarily to scale. Instead, emphasis is placed on illustrating clearly the principles of the present disclosure. Furthermore, components can be shown as transparent in certain views for clarity of illustration only and not to indicate that the illustrated component is necessarily transparent.
Specific details of several embodiments of the technology are described below with reference to
With regard to the terms “distal” and “proximal” within this description, unless otherwise specified, the terms can reference a relative position of the portions of a heart valve repair device and/or an associated delivery device with reference to an operator and/or a location in the vasculature or heart. For example, in referring to a delivery catheter suitable to deliver and position various heart valve repair or replacement devices described herein, “proximal” can refer to a position closer to the operator of the device or an incision into the vasculature, and “distal” can refer to a position that is more distant from the operator of the device or further from the incision along the vasculature (e.g., the end of the catheter). With respect to a prosthetic heart valve repair or replacement device, the terms “proximal” and “distal” can refer to the location of portions of the device with respect to the direction of blood flow. For example, proximal can refer to an upstream-oriented position or a position of blood inflow, and distal can refer to a downstream-oriented position or a position of blood outflow.
Additionally, the term “expanded configuration” refers to the configuration or state of the device when allowed to freely expand to an unrestrained size without the presence of constraining or distorting forces. The terms “deployed configuration” or “deployed” refer to the device after expansion at the native valve site and subject to the constraining and distorting forces exerted by the native anatomy. The terms “extended configuration” or “extended state” refer to the “expanded configuration and/or deployed configuration,” and the terms “contracted configuration” or “contracted state” refer to the device in a compressed or otherwise collapsed state.
For ease of reference, throughout this disclosure identical reference numbers and/or letters are used to identify similar or analogous components or features, but the use of the same reference number does not imply that the parts should be construed to be identical. Indeed, in many examples described herein, the identically numbered parts are distinct in structure and/or function. The headings provided herein are for convenience only.
Overview
Systems, devices and methods are provided herein for percutaneous repair of native heart valves, such as mitral valves. Several of the details set forth below are provided to describe the following examples and methods in a manner sufficient to enable a person skilled in the relevant art to practice, make and use them. Several of the details and advantages described below, however, may not be necessary to practice certain examples and methods of the technology. Additionally, the technology may include other examples and methods that are within the scope of the claims but are not described in detail.
Embodiments of the present technology provide systems, methods and apparatus to treat valves of the body, such as heart valves including the mitral valve. The apparatus and methods enable a percutaneous approach using a catheter delivered intravascularly through a vein or artery into the heart. Additionally, the apparatus and methods enable other less-invasive approaches including trans-apical, trans-atrial, and direct aortic delivery of a heart valve repair device to a target location in the heart. The apparatus and methods enable a prosthetic device to be anchored at or near a native valve location by engaging a subannular surface and other sub-valvular elements of the valve annulus, chordae tendineae, and/or valve leaflets. Additionally, the embodiments of the devices and methods described herein can be combined with many known surgeries and procedures, such as known methods of accessing the valves of the heart (e.g., the mitral valve or tricuspid valve) with antegrade or retrograde approaches, and combinations thereof.
The devices and methods described herein provide a valve repair device that has the flexibility to adapt and conform to the variably-shaped native mitral valve anatomy while physically supporting or bracing (e.g., pushing) the posterior leaflet of the mitral valve toward the anterior leaflet in at least a partially closed position to facilitate coaptation of the native mitral leaflets during systole. Several embodiments of the device effectively reduce the size of the mitral orifice and render the native mitral valve competent. The device has the structural strength and integrity necessary to withstand the dynamic conditions of the heart over time and to permanently anchor the repair device in the subannular position so that the patient can resume a substantially normal life. The systems and methods further deliver such a device in a less-invasive manner to provide a patient with a new, permanent repair device using a lower-risk procedure that has a faster recovery period compared to conventional procedures.
Several embodiments of the present technology include devices for repairing a native valve of a heart. Native heart valves have an annulus and leaflets, and such repair devices include a support for engaging an interior surface of a heart wall and an outward-facing surface (e.g., a backside, underside or downstream side) of a leaflet of the native valve in a subannular position of the native valve. The device can be configured to support the leaflet in an at least partially closed position. In the at least partially closed position the leaflet can be positioned so that valve function is improved, usually by improving the coaptation of the leaflets. For example, in the at least partially closed position the leaflet can be held closer to an opposing leaflet of the native valve such that the two leaflets coapt, or sealingly engage with one another, through a portion of the cardiac cycle. The leaflet may be positioned so that a portion of the leaflet-which may be the free edge of the leaflet or a mid-portion of the leaflet—coapts with a surface of the opposing leaflet with which the leaflet did not coapt prior to treatment. The device can have a support that optionally can include a spine or beam and an extension unit coupled to or extending from or around the spine. In one embodiment, the extension unit can include a biocompatible material suitable to support tissue ingrowth. In various embodiments, the extension unit can include a plurality of projections configured to expand or otherwise extend between and/or engage chordae tendineae associated with the leaflet. In some embodiments, the extension unit comprises a flexible, fluid-impermeable cover, such as an inflatable bladder or balloon, and an injectable filler material within the cover that expands portions of the extension unit and maintains the expanded configuration over time (e.g., filling and expanding the plurality of projections).
Some embodiments of the disclosure are directed to systems to repair a native valve of a patient and implant a prosthetic valve. In one embodiment, the system can have a prosthetic heart valve repair device implantable in a subannular position relative to the native valve and having a support for engaging an interior surface of a heart wall and an outward-facing surface (e.g., a backside, underside or downstream side) of a leaflet of the native valve in a subannular position of the native valve. In this embodiment, the support can be configured to change an annulus shape and/or an annulus cross-sectional dimension when the device is in a deployed configuration. For example, the support can be configured to change the annulus shape from a non-circular cross-section to a more circular or substantially circular cross-section. The system can also include a prosthetic heart valve. The prosthetic heart valve can, for example, include a radially expandable support structure with a lumen and a valve coupled to the support structure in the lumen. In this arrangement, when the prosthetic heart valve repair device is implanted in the subannular position, the radially expandable support structure can be supported within the changed annulus shape or changed annulus cross-sectional dimension. In a particular example, the heart valve repair device can be positioned behind a posterior mitral valve leaflet in a subannular region, and the prosthetic heart valve can have a substantially circular cross-sectional dimension.
Other aspects of the present technology are directed to methods for repairing a native valve of a patient. In one embodiment, a method includes positioning a heart valve repair device in a subannular position behind at least one leaflet connected to chordae tendineae. The repair device can have a support that is initially in a contracted configuration. The method can also include expanding or otherwise extending the support in the subannular position such that the support engages an interior surface of a heart wall and an outward-facing surface (e.g., a backside, underside or downstream side) of the leaflet. In one example, the native valve is a mitral valve and the support can engage a left ventricular wall and a posterior mitral valve leaflet. In exemplary embodiments the support is extended toward a free edge of the leaflet, or toward an opposing leaflet with which the supported leaflet should coapt. In embodiments for mitral valve repair, the support may be extended in an anterior direction (i.e., away from a posterior wall of the ventricle and toward the anterior leaflet), or toward the anterior edge of the posterior leaflet. In various embodiments, the repair device is configured to support the leaflet in at least a partially closed position to facilitate coaptation of the valve leaflets and thereby repair the native valve. This coaptation may occur at the distal free edges of one or both leaflets, or along a middle portion of one or both leaflets.
Another embodiment of the disclosure is directed to a heart valve repair device to treat a native valve of a patient. In various arrangements, the repair device can comprise a frame having a first end configured to be placed at least proximate a first commissure of the native valve and a second end configured to be placed at least proximate a second commissure of the native valve. The frame can further include a curved region between the first and second ends. The curved region of the frame can be configured to engage a backside of a leaflet of the native heart valve such that the leaflet at least partially coapts with an adjacent leaflet of the native valve.
The devices and methods disclosed herein can be configured for treating non-circular, asymmetrically shaped valves and bileaflet or bicuspid valves, such as the mitral valve. It can also be configured for treating other valves of the heart such as the tricuspid valve. Many of the devices and methods disclosed herein can further provide for long-term (e.g., permanent) and reliable anchoring of the prosthetic device even in conditions where the heart or native valve may experience gradual enlargement or distortion.
Cardiac and Mitral Valve Physiology
Referring back to
Referring now to
Referring back to
A person of ordinary skill in the art will recognize that the dimensions and physiology of the mitral valves may vary among patients, and although some patients may comprise differing physiology, the teachings as described herein can be adapted for use by many patients having various conditions, dimensions and shapes of the mitral valve. For example, work in relation to embodiments suggests that some patients may have a long dimension across the annulus and a short dimension across the annulus without well-defined peak and valley portions, and the methods and device as described herein can be configured accordingly.
Access to the Mitral Valve
Access to the mitral valve or other atrioventricular valves can be accomplished through the patient's vasculature in a percutaneous manner. By percutaneous it is meant that a location of the vasculature remote from the heart is accessed through the skin; typically using a surgical cut down procedure or a minimally invasive procedure, such as using needle access through, for example, the Seldinger technique. The ability to percutaneously access the remote vasculature is well-known and described in the patent and medical literature. Depending on the point of vascular access, the approach to the mitral valve may be antegrade and may rely on entry into the left atrium by crossing the inter-atrial septum. Alternatively, approach to the mitral valve can be retrograde where the left ventricle is entered through the aortic valve. Once percutaneous access is achieved, the interventional tools and supporting catheter(s) may be advanced to the heart intravascularly and positioned adjacent the target cardiac valve in a variety of manners.
An example of a retrograde approach to the mitral valve is illustrated in
In some specific instances, a retrograde arterial approach to the mitral valve may be selected due to certain advantages. For example, use of the retrograde approach can eliminate the need for a trans-septal puncture (described below). The retrograde approach is also more commonly used by cardiologists and thus has the advantage of familiarity.
An additional approach to the mitral valve is via trans-apical puncture, as shown in
The trans-apical approach has the feature of providing a shorter, straighter, and more direct path to the mitral or aortic valve. Further, because it does not involve intravascular access, the trans-apical procedure can be performed by surgeons who may not have the necessary training in interventional cardiology to perform the catheterizations required in other percutaneous approaches.
Using a trans-septal approach, access is obtained via the inferior vena cava IVC or superior vena cava SVC, through the right atrium RA, across the inter-atrial septum IAS and into the left atrium LA above the mitral valve MV.
As shown in
As shown in
In an alternative antegrade approach (not shown), surgical access may be obtained through an intercostal incision, preferably without removing ribs, and a small puncture or incision may be made in the left atrial wall. A guide catheter may then be placed through this puncture or incision directly into the left atrium, sealed by a purse string-suture.
The antegrade or trans-septal approach to the mitral valve, as described above, can be advantageous. For example, the antegrade approach may decrease risks associated with crossing the aortic valve as in retrograde approaches. This can be particularly relevant to patients with prosthetic aortic valves, which may not be crossed at all or without substantial risk of damage.
The prosthetic valve repair device may also be implanted using conventional open-surgical approaches. For some patients, the devices and methods of the invention may offer a therapy better suited for the treatment of certain valve pathologies or more durable than existing treatments such as annuloplasty or valve replacement.
The prosthetic valve repair device may be specifically designed for the approach or interchangeable among approaches. A person of ordinary skill in the art can identify an appropriate approach for an individual patient and design the treatment apparatus for the identified approach in accordance with embodiments described herein.
Orientation and steering of the prosthetic valve repair device can be combined with many known catheters, tools and devices. Such orientation may be accomplished by gross steering of the device to the desired location and then refined steering of the device components to achieve a desired result.
Gross steering may be accomplished by a number of methods. A steerable guidewire may be used to introduce a guide catheter and the prosthetic valve repair device into the proper position. The guide catheter may be introduced, for example, using a surgical cut down or Seldinger access to the femoral artery in the patient's groin. After placing a guidewire, the guide catheter may be introduced over the guidewire to the desired position. Alternatively, a shorter and differently shaped guide catheter could be introduced through the other routes described above.
A guide catheter may be pre-shaped to provide a desired orientation relative to the mitral valve. For access via the trans-septal approach, the guide catheter may have a curved, angled or other suitable shape at its tip to orient the distal end toward the mitral valve from the location of the septal puncture through which the guide catheter extends. For the retrograde approach, as shown in
Selected Embodiments of Prosthetic Heart Valve Repair Devices and Methods
Embodiments of the present technology can be used to treat one or more of the valves of the heart as described herein, and several embodiments are well suited for treating the mitral valve. Introductory examples of prosthetic heart valve repair devices, system components, and associated methods in accordance with embodiments of the present technology are described in this section with reference to
Systems, devices and methods in accordance with the present technology provide percutaneous implantation of prosthetic heart valve repair devices in a heart of a patient. In some embodiments, methods and devices treat valve diseases by minimally invasive implantation of repair devices behind one or more native leaflets in a subannular position using the techniques described above with respect to
In the embodiment shown in
The support 110 can be pre-shaped such that upon deployment, the repair device 100 accommodates (e.g., approximates) the shape of the native anatomy or the desired post-treatment shape of the native anatomy. For example, the support 110 can be pre-shaped to expand into a “C” shape or other suitably curved shape to accommodate the curvature of the mitral valve annulus and/or to conform to a portion of the native mitral valve annulus. In some embodiments, several components of the support 110 can have a subannular engaging surface 118 that includes one or more peaks (not shown) and one or more valleys (not shown) in the upstream-downstream direction for accommodating or conforming to the native saddle-shape contour of the mitral annulus. An outer edge 117 of the curved region 116 of the support 110 can be positionable against the interior surface of the heart wall.
Referring to
The support 110 can further include an extension unit 120 attached to and/or positioned around at least a portion of the spine 111. In one embodiment, for example, the extension unit 120 can be biocompatible with cardiac tissue at or near the native valve of the patient so as to promote tissue ingrowth and strengthen implantation of the repair device 100 within the native valve region. In exemplary embodiments, extension unit 120 can comprise a flexible cover of biocompatible fabric or polymer that surrounds spine 111. In one embodiment, the extension unit 120 can include an expandable member, such as an expandable tube, balloon, bladder, foam or other expandable material, that is coupled to the spine 111. The expandable member may itself surround spine 111, may be held within a flexible fabric or polymeric cover extending around or attached to spine 111, or may be attached directly to a lateral side of spine 111. For example, the extension unit 120 can be an elastic or inelastic balloon made from impermeable, flexible biocompatible materials. The extension unit 120 can comprise a fabric or other flexible, stretchable and/or biocompatible material such as braided, woven, or crocheted Dacron®, expanded PTFE (Gore-Tex®), bovine pericardium, or other suitable flexible material to integrate with adjacent tissue and promote tissue ingrowth to facilitate further stability of the repair device 100 in the subannular position. In other embodiments, the extension unit 120 can include polyester fabric, a polymer, thermoplastic polymer, a synthetic fiber, a natural fiber or polyethylene terephthalate (PET). Several embodiments of the extension unit 120 may be pre-shaped to accommodate a relatively fixed maximal dimension and shape when the repair device 100 is implanted. In various embodiments, the extension unit 120 can be porous and/or adhere to the interior surface of the heart wall and/or the backside of the leaflet. Tissue ingrowth into the extension unit 120 can form a pannus of tissue which is hemocompatible and can strengthen the combined structure of the repair device 100, the subannular tissue and/or interior surface of the heart wall, and the backside of the leaflet. Extension unit 120 will be expandable (e.g., in a transverse or radial direction relative to the longitudinal axis of the spine 111) from a collapsed configuration for endovascular or trans-apical delivery to an expanded configuration suitable for bracing the valve leaflet in the desired position. Extension unit 120 will usually be more flexible than spine 111 when in an unexpanded configuration, and in some embodiments will become substantially more rigid when expanded, e.g. by filling or inflating with a fluid. This rigidity may be imparted solely by fluid pressure, or by hardening or curing the fluid (e.g. epoxy or cement) within the extension unit.
The support 110 can further include a plurality of projections 130 and depressions 131 in the expanded configuration. The projections 130 alternate with depressions 131 such that each depression is disposed between two projections, forming a series of peaks and valleys. For example, the projections 130 can be features of the extension unit 120 that extend toward the other native leaflet and generally parallel to the underside of the supported leaflet such that the projections 130 extend between and engage the secondary and/or tertiary chordae tendineae that tether the leaflet (e.g., the mitral valve posterior leaflet) to the ventricular wall. In some embodiments all or a portion of the projections 130 may extend in generally the same (anterior) direction, while in other embodiments the projections 130 may extend in a radially inward direction relative to the curvature of the spine 111 (or native valve annulus). As such, a portion of the secondary and/or tertiary chordae tendineae can be positioned in the depressions 131 after the repair device 100 has been deployed. The upper or leaflet-facing sides of the projections 130 are preferably smooth and wide enough to support the leaflet without abrading or damaging the leaflet should it move or rub against the projections during the cardiac cycle. The depressions 131 are preferably wide enough to receive at least one of the chordae somewhat snugly to inhibit lateral movement of the support.
Referring still to
The side of the support opposite the projections 130 (i.e., posterior side in mitral embodiments) will preferably be configured to atraumatically and compressively engage the ventricular wall to assist in anchoring the device in place. The posterior surface may be a soft, compressive, and resilient material, preferably atraumatic to the heart wall, and preferably one that encourages tissue in-growth. In some embodiments, the posterior side may have retention elements, e.g. spikes, hooks, bristles, points, bumps, or ribs, protruding from its surface, to engage the ventricular wall to further assist in anchoring and immobilizing the device. The posterior side may also have one or more expandable, resilient, or spring-like elements thereon that engage the ventricular wall and urge the support 110 in the anterior direction (away from the wall) to firmly and compressively engage the chordae tendonae between the projections 130. This can supplement or substitute for the expansion of the support 110 or extension member.
In other embodiments, the repair device 100 may include a fluid absorbing material that expands after implantation by absorption of blood or other fluids to inflate the extension unit 120 either in addition to or in lieu of using the inflation tube 1240. For example, the extension unit 120 may have a fluid permeable cover and an absorbent material within the cover that expands as it absorbs fluid, or the extension unit 120 can be a foam that expands to form the projections 130. Alternatively, the extension unit 120 may be filled with a fluid absorbing substance such as a biocompatible hydrogel which expands when exposed to blood or other fluid. In this way, the support 110 may be implanted and optionally expanded partially, then allowed to expand to its fully expanded configuration by absorption of fluids. Alternatively, the extension unit 120 may be sufficiently porous to allow blood to pass into it such that blood will collect and fill up the extension unit. Eventually, the blood may clot and be replaced by tissue to strengthen and rigidify the repair device 100. In further embodiments, the extension unit 120 may be configured to receive an injectable material to realize a fully-expanded configuration.
The overall cross-sectional shape of the repair device 100 can determine the resting location of the posterior leaflet PL as it is braced in the at least partially closed position. Therefore, the distances DV and DL, and the curvatures of the ventricular wall engaging surface 150 and the posterior leaflet engaging surface 160, can be configured to accommodate different anatomical requirements of different patients. For example,
configured in accordance with another embodiment of the present technology. The repair device 100b shown in
As shown in
Repair devices in accordance with any of the foregoing embodiments can have other shapes, dimensions, sizes and configurations to address patient specific anatomy or to otherwise achieve coaptation of the native valve leaflets in a specific patient. The shape and dimension of the repair device 100 may be selected such that the posterior leaflet is braced in a position which results in sealing coaptation of the posterior and anterior leaflets during systole. The repair device 100 may be adjustable in size or shape before or after placement to allow the physician to adjust the device to achieve the desired post-treatment leaflet position. For example, the repair device 100 may have malleable portions that can be manually shaped by the physician, mechanically articulating portions that can be remotely adjusted, or inflatable portions into which a fluid may be injected to change their shape or size.
One aspect of several embodiments of the repair devices 100-100c described above is that the support 110 is secured at the target site without anchors or other components that pierce the tissue of the leaflets, annulus and/or the wall of the heart. For example, the combination of expanding or otherwise extending the projections 130 between the chordae tendineae and pressing the support 110 against the underside of the posterior leaflet and the wall of the left ventricle securely holds the repair device in place. This is expected to simplify the treatment and reduce trauma to the heart.
In other embodiments, repair device 100 may have features on its exterior to enhance fixation with the native tissue. For example, the posterior surface that engages the wall of the ventricle, and/or the upper surface that engages the posterior leaflet, may have barbs, bumps, ribs, spikes, or other projections configured to engage the tissue and enhance fixation through friction or by penetration of the tissue surface. Additionally or alternatively, friction-enhancing fabrics, polymers or other materials may be provided on these surfaces. In other embodiments, loops or hooks may be coupled to repair device 100 which are configured to engage with or extend around the chordae or papillary muscles. Further, the material used to cover repair device 100 may enhance tissue ingrowth such that the device is encapsulated in tissue within a short time after implantation.
Another aspect of several embodiments of the repair devices 100-100c is that the degree to which the projections 130 of the extension unit 120 extend in an anterior direction can be controlled to custom tailor the repair device 100 to the anatomy of a specific patient. For example, when the extension unit 120 is an inflatable bladder or balloon, the distance that the projections 130 extend in the anterior direction can be controlled by the amount of filler material 140 that is injected into the extension unit 120. This is expected to provide enhanced flexibility and customization of the repair device 100.
Various aspects of the present technology provide heart valve repair devices that can reduce the effective annular area of the mitral valve orifice, by holding the posterior leaflet permanently closed, or in other embodiments mostly closed, or in further embodiments in an extended position beyond its natural closed position state. When the repair device is deployed at the target region of the mitral valve, the native valve may have only a functional anterior leaflet, thereby reducing the effective orifice area. Not to be bound by theory, the remaining effective orifice area is believed to be sufficient to avoid a physiologically detrimental or an excessive pressure gradient through the mitral orifice during systole. Regurgitant mitral valves typically have dilated to a size much larger than their original area, so a reduction in the orifice area may not compromise the valve. Additionally, many conventional mitral valve repair surgeries result in a posterior leaflet that extends only a very short distance from the posterior annulus. After these surgeries, the motion of the anterior leaflet provides nearly all of the orifice area. Accordingly, immobilization of the posterior leaflet of a dilated mitral valve in the closed position is not believed to lead to hemodynamic complications due to a high pressure gradient during antegrade flow through the valve.
Following implantation and deployment of the repair device in the target location, and while the device extends and holds the posterior leaflet of the mitral valve at least partially in the closed position, the device additionally can apply tension from the valve leaflet to the chordae tendineae attached to the papillary muscles and the ventricular wall. This additional tension applied by the implanted repair device can, in some embodiments, pull the papillary muscles and the free wall of the left ventricle closer to the mitral valve to reduce the tethering effect on the anterior leaflet and allow the anterior leaflet to close more effectively. Thus, in addition to the hemodynamic benefit of a competent mitral valve by at least partially closing the posterior leaflet, the device might slightly improve morphology of both the anterior leaflet and the left ventricle, and help the valve to provide a structural benefit to the ventricle.
In another aspect of the present technology, several embodiments of the repair device 100 can be used in conjunction with a prosthetic heart valve replacement device delivered percutaneously or trans-apically to treat an abnormal or diseased native heart valve. Percutaneous or transapical replacement of the mitral valve is particularly challenging due, at least in part, to the non-circular, large, and asymmetric shape of the mitral annulus. In addition, a diseased mitral valve can enlarge over time making implantation of a percutaneous prosthetic heart valve even more challenging. In accordance with an embodiment of the present technology, the repair device 100 can be configured to change either an annulus shape or an annulus cross-sectional dimension when the device 100 is in the deployed configuration. In a particular example, the repair device 100 can be implanted in the sub annular position behind a posterior leaflet PL of a native mitral valve MV to decrease the effective size of the mitral valve annulus. In another embodiment, the repair device 100 can be configured to change the native annulus shape to a more circular shape or having a circular orifice, which may be advantageous for receiving some variations of implantable prosthetic heart valves. In one embodiment, the repair device 100 may be implanted in a first surgical step and implantation of a prosthetic heart valve device may occur at a second surgical step either immediately or at some future date.
In one example, the smaller and/or circular native mitral valve orifice 170 may be able to accommodate valve prostheses designed for implantation in circular orifices, such as aortic valve replacement devices. For example,
As described above with respect to
In one embodiment, positioning of a heart valve repair device can include placing a percutaneously positioned guide catheter with its distal tip approaching one of the mitral valve commissures and positioned at the end of the groove behind the posterior leaflet. A steerable guidewire and flexible catheter can then be advanced from the guide catheter around the groove behind the posterior leaflet and in the direction of the other opposite commissure. Once the catheter is in place, the guidewire can be withdrawn and the repair device can be introduced (e.g., in a contracted configuration) through the flexible catheter. If necessary, a flexible secondary guiding catheter or sheath can be placed over the guidewire or catheter before introducing the repair device. The repair device can be contained in the contracted configuration by a thin extension unit or sheath during the introduction process. Once the repair device is positioned behind the posterior leaflet, the sheath is withdrawn and the device is deployed or inflated. Further guidance can be used to ensure that the projections, if present, expand between the tertiary chordae tendineae. In some embodiments, radiopaque markers can be incorporated in known locations on the catheter, the sheath, or the repair device to ensure proper delivery to the target location.
The repair devices, systems and methods disclosed herein may also be used to repair and/or treat regurgitant tricuspid valves. The tricuspid valve, like the mitral valve, has leaflets tethered by chordae tendineae. Such a repair device as disclosed herein might be deployed behind one, two or all three of the tricuspid valve leaflets.
In still further applications, embodiments of the repair devices in accordance with the present technology can be used to enhance the functionality of various prosthetic valves. For example, the repair device can be configured to push or brace prosthetic leaflets or prosthetic aptation devices implanted at a native heart valve thereby facilitating coaptation of the prosthetic leaflets. In particular examples, several embodiments of repair devices in accordance with the present technology can be used to at least partially coapt (a) the prosthetic aptation devices shown and described in U.S. Pat. No. 7,404,824 B1, filed by Webler et al. on Nov. 12, 2003, which is herein incorporated by reference or (b) the prosthetic leaflets of devices shown and described in U.S. Pat. No. 6,730,118, filed by Spenser et al. on Oct. 11, 2002 and/or U.S. Patent Publication No. 2008/0243245, filed by Thambar et al. on May 28, 2008, which is also incorporated herein by reference. In another embodiment, several embodiments of repair devices in accordance with the present technology can also be used concomitantly with other valve therapies, such as the MitraClip® device sold by Abbott Laboratories, which connects the free edges of the two leaflets of the mitral valve.
Various aspects of the present disclosure provide heart valve repair devices, systems and methods for bracing at least a portion of the posterior leaflet of the native mitral valve in a closed or partially closed position to reduce or eliminate regurgitation occurrence in the mitral valve, while retaining enough effective valve area to prevent any significant pressure gradient across the mitral valve. Other aspects of the present disclosure provide heart valve repair devices, systems and methods for reducing the effective area of the mitral orifice and/or rendering a mitral valve competent without substantially reshaping the native annulus. Additionally, while additional tethering or anchoring mechanisms known in the art can be used to anchor the device in the target location, the devices described herein do not require additional tethering or anchoring mechanisms.
Features of the prosthetic heart valve device components described above also can be interchanged to form additional embodiments of the present technology. For example, the appendage 135 of the repair device 101 illustrated in
The following Examples are illustrative of several embodiments of the present technology.
1. A method of repairing a native mitral valve having an anterior leaflet and a posterior leaflet between a left atrium and a left ventricle, comprising:
2. A method of repairing a native mitral valve having an anterior leaflet and a posterior leaflet between a left atrium and a left ventricle, comprising:
3. The method of any of examples 1-2 wherein causing the support to press against the underside of the posterior leaflet or engaging the underside of the posterior leaflet with the support comprises projecting at least a portion of the support in an anterior direction such that the support urges a portion of the posterior leaflet towards the anterior leaflet.
4. The method of any of examples 1-3 wherein:
5. The method of example 4 wherein the extension unit comprises an inflatable bladder and extending the extension unit comprises injecting an inflation medium into the inflatable bladder.
6. The method of example 5 wherein the inflation medium comprises a biocompatible fluid.
7. The method of example 5 wherein the inflation medium comprises a curable fluid that is injected into the bladder in a fluidic state and then cures to a hardened state.
8. The method of example 4 wherein the extension unit comprises a self-expanding metal structure and extending at least a portion of the extension unit comprises releasing the self-expanding metal structure from a collapsed state such that the self-expanding metal structure presses against the underside of the posterior leaflet.
9. The method of any of examples 1-8 wherein the support comprises a plurality of projections and a plurality of depressions, each depression being disposed between two of the projections, and causing the support to press against an underside of the posterior leaflet or engaging the underside of the posterior leaflet with the support comprises extending the projections along the underside of the posterior leaflet such that an upper side of the projections presses against the posterior leaflet and the chordae tendineae are positioned in at least some of the depressions.
10. A method for repairing a native valve of a patient, the method comprising:
11. The method of example 10 wherein the native valve is a mitral valve, and wherein the heart wall is a left ventricular wall and the leaflet is a posterior mitral valve leaflet.
12. The method of examples 10 or 11 wherein prior to positioning the heart valve repair device the patient has mitral valve regurgitation, and wherein the repair device reduces the regurgitation after expanding the support in the subannular position.
13. The method of any one of examples 10-12 wherein the support comprises an extension unit configured to expand along the downstream-facing surface of the at least one leaflet.
14. The method of example 13 wherein the extension unit is configured to expand in a direction toward a free edge of the at least one leaflet.
15. The method of example 13 wherein tissue grows into the extension unit after the repair device braces the leaflet in the partially closed position.
16. The method of any one of examples 13-15 wherein the extension unit comprises a plurality of projections configured to extend between the chordae tendineae connected to the leaflet.
17. The method of any one of examples 13-16, further comprising injecting a filler material into the extension unit.
18. The method of example 17 wherein the filler material fills and expands the plurality of projections so as to extend between the chordae tendineae.
19. The method of example 10 wherein, after expanding, the support is held in place by chordae tendineae attached to the leaflet.
20. The method of example 19 wherein the support is retained between the chordae tendineae and the leaflet and a subannular wall of the heart.
21. The method of examples 19 or 20 wherein the chordae tendineae are basal or tertiary chordae tendineae.
22. The method of example 10 wherein the repair device is held in place without penetrating the leaflet or heart wall tissue.
23. The method of example 10, further comprising releasing the repair device at the subannular position from a delivery device, wherein the repair device resides substantially entirely on the subannular side of the leaflet after being released from the delivery device.
24. The method of example 10, further comprising releasing the repair device at the subannular position from a delivery device, wherein the support maintains the leaflet so as not to open wider than the partially closed position after being released from the delivery device.
25. The method of example 24 wherein the support allows the leaflet to move between the partially closed position and a completely closed position during a cardiac cycle.
26. The method of example 10 wherein the support maintains a first leaflet of the valve in the partially closed position so as to sealingly engage a second leaflet of the valve during a portion of a cardiac cycle.
27. The method of example 10 wherein the repair device further comprises at least one retention member, wherein the retention member extends through or between one or more of the valve leaflets to a super-annular side thereof to maintain the support in the subannular position.
28. The method of example 10 wherein the repair device further comprises at least one retention member configured to engage the inward facing wall of the heart.
29. The method of example 10 wherein the support is expanded by injecting a fluid therein.
30. The method of example 10 wherein expanding the support includes releasing the support from a constrained configuration such that the support self-expands to an expanded configuration.
31. The method of example 10 wherein the support is expanded at least partially by absorption of blood or other body fluids.
32. The method of example 10 wherein an effective orifice area of the valve is reduced when the support is expanded.
33. The method of example 10 wherein expansion of the support changes the shape of an annulus of the valve and/or a shape of a functional orifice of the valve.
34. The method of example 10 wherein expansion of the support repositions the at least one leaflet such that an inward facing surface thereof coapts with an opposing surface of a second leaflet of the native valve during at least a portion of the cardiac cycle.
35. The method of example 10 wherein the placement and expansion of the support does not substantially change the shape of an annulus of the valve.
36. A repair device for repairing a native mitral valve having an anterior leaflet and a posterior leaflet between a left atrium and a left ventricle, the repair device comprising:
37. The repair device of example 36, wherein the support comprises an extension unit configured to push at least a portion of the leaflet towards an opposing leaflet of the native valve.
38. The repair device of example 37 wherein the extension unit is expandable from a contracted configuration to an expanded configuration.
39 The repair device of example 38 wherein the extension unit comprises an inflatable or fillable member.
40. The repair device of example 39, further comprising a port in communication with the inflatable or fillable member for delivering a fluid thereto.
41. The repair device of example 37 wherein the support comprises an elongated spine, the extension unit being coupled to the spine.
42. The repair device of example 41 wherein the extension unit is substantially more flexible than the spine in the contracted configuration.
43. The repair device of example 41 wherein the spine has a longitudinal axis and the extension unit is configured to expand in a direction transverse to the longitudinal axis.
44. The repair device of example 41 wherein the spine is curved in an unconstrained state and the extension unit is configured to expand in a radial direction relative to the spine.
45. The repair device of example 37 wherein the extension unit comprises a flexible cover extending around the spine.
46. The repair device of example 45 wherein the flexible cover is inflatable or fillable with a fluid.
47. The repair device of example 37 wherein the extension unit is substantially more rigid in the expanded configuration.
48. The repair device of example 36 wherein the support is formed of a biocompatible material for promoting tissue ingrowth.
49. The repair device of any one of examples 36-48 wherein the support is expandable.
50. The repair device of any one of examples 36-49 wherein the support is configured to conform to a shape defined by native tissue in the subannular position.
51. The repair device of example 50 wherein the support is configured to be held in place by chordae tendineae attached to the valve leaflet.
52. The repair device of example 51 wherein the support is configured to be compressively retained between the chordae tendineae and the leaflet and a subannular wall of the heart.
53. The repair device of example 36 wherein the support is configured to be held in the subannular position without penetrating the leaflet or heart wall tissue.
54. The repair device of example 36 wherein the support is configured to reside substantially entirely on the subannular side of the leaflet.
55. The repair device of example 36 wherein the support is configured to maintain the leaflet so as not to open wider than the partially closed position.
56. The repair device of example 55 wherein the support is configured to allow the leaflet to move between the partially closed position and a completely closed position during a cardiac cycle.
57. The repair device of example 36 wherein the support maintains a first leaflet of the valve in the partially closed position so as to sealingly engage a second leaflet of the valve during a portion of a cardiac cycle.
58. The repair device of any one of examples 36-57 wherein the repair device has a triangular or polygonal cross-section.
59. The repair device of any one of examples 36-58 wherein the repair device includes a plurality of projections configured to expand between and engage chordae tendineae attached to the leaflet.
60. The repair device of example 59 wherein the support is preformed to include the plurality of projections when in a deployed configuration.
61. The repair device of example 60 wherein the support includes at least one bladder configured to receive filler material, and wherein the support is expandable with the filler material to form the plurality of projections when the repair device is in a deployed configuration.
62. The repair device of example 36-61 wherein the support has a first radial cross-section near a first end of the support, a second radial cross-section near a second end of the support, and a third radial cross-section near a central region of the support, and wherein the first, second, and third radial cross-sections are substantially equal.
63. The repair device of example 36-62 wherein the support has a first radial cross-section near a first end of the support, a second radial cross-section near a second end of the support, and a third radial cross-section near a central region of the support, and wherein the third radial cross-section is greater than the first and second radial cross-sections.
64. The repair device of example 36-61 wherein the support has a first radial cross-section near a first end of the support, a second radial cross-section near a second end of the support, and a third radial cross-section near a central region of the support, and wherein the first radial cross-section is greater than the second and third radial cross-sections.
65. The repair device of any one of examples 36-64 wherein the support engages an outward-facing surface of a plurality of leaflets.
66. The repair device of any one of examples 36-65 wherein the native valve is a mitral valve, and wherein the support is configured to engage an underside of a posterior leaflet of the mitral valve.
67. The repair device of example 66 wherein the support is configured to reside substantially entirely under the posterior leaflet.
68. The repair device of any one of examples 36-66 wherein the native valve is a tricuspid valve, and wherein the support is configured to engage an underside of a leaflet of the tricuspid valve.
69. The repair device of any one of examples 36-66 wherein the native valve is a mitral valve, and wherein the support is configured to—
70. The repair device of any one of examples 36-69 wherein the support includes a flexible and resilient spine.
71. The repair device of example 70 wherein the spine is one of a wire, a stent structure, a coiled spring or a braided tube.
72. The repair device of example 70 wherein the support further comprises a flexible cover extending around the spine.
73. The repair device of example 72 wherein the flexible cover is inflatable or fillable with a fluid.
74. The repair device of any one of examples 36-70 wherein the support is self-expanding.
75. The repair device of any one of examples 36-70 wherein the support includes at least one of nitinol or stainless steel.
76. The repair device of any one of examples 36-70 wherein the support expands to form a “C” shape to conform to a portion of a native mitral valve.
77. The repair device of any one of examples 36-70 wherein the support includes a subannular engaging surface, and wherein the subannular engaging surface includes one or more peaks and one or more valleys.
78. A system to treat a native valve of a patient, the system comprising:
79. The system of example 78, further comprising a delivery catheter having a lumen configured to retain the prosthetic valve device in a delivery configuration having a lower profile than the deployed configuration.
80. The system of examples 78 or 79 wherein the native valve has a plurality of native leaflets joined at commissures, and wherein the support is configured to engage the outward-facing surface of at least one leaflet and extend beyond the commissures.
81. The system of example 80 wherein the native valve is a mitral valve, and wherein the support is configured to—
82. The system of any one of examples 78-81 wherein the prosthetic heart valve has a substantially circular cross-sectional dimension.
83. The system of example 82 wherein the support is configured to change the effective annulus shape from a non-circular cross-section to a substantially circular cross-section.
The above detailed descriptions of embodiments of the technology are not intended to be exhaustive or to limit the technology to the precise form disclosed above. Although specific embodiments of, and examples for, the technology are described above for illustrative purposes, various equivalent modifications are possible within the scope of the technology as those skilled in the relevant art will recognize. For example, although steps are presented in a given order, alternative embodiments may perform steps in a different order. The various embodiments described herein may also be combined to provide further embodiments. The embodiments, features, systems, devices, materials, methods and techniques described herein may, in certain embodiments, be applied to or used in connection with any one or more of the embodiments, features, systems, devices, materials, methods and techniques disclosed in U.S. Provisional Patent Application No. 61/825,491, which is incorporated herein by reference in its entirety.
From the foregoing, it will be appreciated that specific embodiments of the technology have been described herein for purposes of illustration, but well-known structures and functions have not been shown or described in detail to avoid unnecessarily obscuring the description of the embodiments of the technology. Where the context permits, singular or plural terms may also include the plural or singular term, respectively.
Moreover, unless the word “or” is expressly limited to mean only a single item exclusive from the other items in reference to a list of two or more items, then the use of “or” in such a list is to be interpreted as including (a) any single item in the list, (b) all of the items in the list, or (c) any combination of the items in the list. Additionally, the term “comprising” is used throughout to mean including at least the recited feature(s) such that any greater number of the same feature and/or additional types of other features are not precluded. It will also be appreciated that specific embodiments have been described herein for purposes of illustration, but that various modifications may be made without deviating from the technology. Further, while advantages associated with certain embodiments of the technology have been described in the context of those embodiments, other embodiments may also exhibit such advantages, and not all embodiments need necessarily exhibit such advantages to fall within the scope of the technology. Accordingly, the disclosure and associated technology can encompass other embodiments not expressly shown or described herein.
The present application is a continuation of U.S. patent application Ser. No. 16/273,065, filed Feb. 11, 2019, now U.S. Pat. No. 10,820,996, which is a continuation of U.S. patent application Ser. No. 15/241,155, filed Aug. 19, 2016, entitled “IMPLANTABLE HEART VALVE DEVICES, MITRAL VALVE REPAIR DEVICES AND ASSOCIATED SYSTEMS AND METHODS”, now U.S. Pat. No. 10,238,490, which claims priority to U.S. Provisional Patent Application No. 62/208,458, filed Aug. 21, 2015, entitled “IMPLANTABLE HEART VALVE DEVICES, MITRAL VALVE REPAIR DEVICES AND ASSOCIATED SYSTEMS AND METHODS”, both of which are incorporated by reference in their entireties.
Number | Name | Date | Kind |
---|---|---|---|
3526219 | Balamuth | Sep 1970 | A |
3565062 | Kuris | Feb 1971 | A |
3589363 | Banko | Jun 1971 | A |
3667474 | Lapkin et al. | Jun 1972 | A |
3823717 | Pohlman et al. | Jul 1974 | A |
3861391 | Antonevich et al. | Jan 1975 | A |
3896811 | Storz | Jul 1975 | A |
4042979 | Angell | Aug 1977 | A |
4188952 | Loschilov et al. | Feb 1980 | A |
4431006 | Trimmer et al. | Feb 1984 | A |
4445509 | Auth | May 1984 | A |
4484579 | Meno et al. | Nov 1984 | A |
4490859 | Black et al. | Jan 1985 | A |
4587958 | Noguchi et al. | May 1986 | A |
4589419 | Laughlin et al. | May 1986 | A |
4602911 | Ahmadi et al. | Jul 1986 | A |
4646736 | Auth | Mar 1987 | A |
4692139 | Stiles | Sep 1987 | A |
4747821 | Kensey et al. | May 1988 | A |
4750902 | Wuchinich et al. | Jun 1988 | A |
4777951 | Cribier et al. | Oct 1988 | A |
4787388 | Hofmann | Nov 1988 | A |
4796629 | Grayzel | Jan 1989 | A |
4808153 | Parisi | Feb 1989 | A |
4819751 | Shimada et al. | Apr 1989 | A |
4841977 | Griffith et al. | Jun 1989 | A |
4870953 | DonMicheal et al. | Oct 1989 | A |
4878495 | Grayzel | Nov 1989 | A |
4898575 | Fischell et al. | Feb 1990 | A |
4909252 | Goldberger | Mar 1990 | A |
4919133 | Chiang | Apr 1990 | A |
4920954 | Alliger et al. | May 1990 | A |
4936281 | Stasz | Jun 1990 | A |
4960411 | Buchbinder | Oct 1990 | A |
4960424 | Grooters | Oct 1990 | A |
4986830 | Owens et al. | Jan 1991 | A |
4990134 | Auth | Feb 1991 | A |
5058570 | Idemoto et al. | Oct 1991 | A |
5069664 | Guess et al. | Dec 1991 | A |
5076276 | Sakurai et al. | Dec 1991 | A |
5106302 | Farzin-nia et al. | Apr 1992 | A |
5248296 | Alliger | Sep 1993 | A |
5267954 | Nita | Dec 1993 | A |
5269291 | Carter | Dec 1993 | A |
5295958 | Shturman | Mar 1994 | A |
5304115 | Pflueger et al. | Apr 1994 | A |
5314407 | Auth et al. | May 1994 | A |
5318014 | Carter | Jun 1994 | A |
5332402 | Teitelbaum | Jul 1994 | A |
5344426 | Lau et al. | Sep 1994 | A |
5344442 | Deac | Sep 1994 | A |
5352199 | Tower | Oct 1994 | A |
5356418 | Shturman | Oct 1994 | A |
5397293 | Alliger et al. | Mar 1995 | A |
5411025 | Webster, Jr. et al. | May 1995 | A |
5411552 | Andersen et al. | May 1995 | A |
5443446 | Shturman | Aug 1995 | A |
5449373 | Pinchasik et al. | Sep 1995 | A |
5489297 | Duran | Feb 1996 | A |
5584879 | Reimold et al. | Dec 1996 | A |
5609151 | Mulier et al. | Mar 1997 | A |
5626603 | Venturelli et al. | May 1997 | A |
5656036 | Palmaz | Aug 1997 | A |
5662671 | Barbut et al. | Sep 1997 | A |
5662704 | Gross et al. | Sep 1997 | A |
5681336 | Clement et al. | Oct 1997 | A |
5695507 | Auth et al. | Dec 1997 | A |
5725494 | Brisken | Mar 1998 | A |
5782931 | Yang et al. | Jul 1998 | A |
5817101 | Fiedler | Oct 1998 | A |
5827229 | Auth et al. | Oct 1998 | A |
5827321 | Roubin et al. | Oct 1998 | A |
5840081 | Andersen et al. | Nov 1998 | A |
5853422 | Huebsch et al. | Dec 1998 | A |
5855601 | Bessler et al. | Jan 1999 | A |
5868781 | Killion | Feb 1999 | A |
5873811 | Wang et al. | Feb 1999 | A |
5904679 | Clayman | May 1999 | A |
5910129 | Koblish et al. | Jun 1999 | A |
5957882 | Nita et al. | Sep 1999 | A |
5972004 | Williamson, IV et al. | Oct 1999 | A |
5989208 | Nita | Nov 1999 | A |
5989280 | Euteneuer et al. | Nov 1999 | A |
6047700 | Eggers et al. | Apr 2000 | A |
6050188 | Bolza-Schunemann | Apr 2000 | A |
6056759 | Fiedler | May 2000 | A |
6085754 | Alferness et al. | Jul 2000 | A |
6113608 | Monroe et al. | Sep 2000 | A |
RE36939 | Tachibana et al. | Oct 2000 | E |
6129734 | Shturman et al. | Oct 2000 | A |
6132444 | Shturman et al. | Oct 2000 | A |
6168579 | Tsugita | Jan 2001 | B1 |
6217595 | Shturman et al. | Apr 2001 | B1 |
6254635 | Schroeder et al. | Jul 2001 | B1 |
6295712 | Shturman et al. | Oct 2001 | B1 |
6306414 | Koike | Oct 2001 | B1 |
6321109 | Ben-haim et al. | Nov 2001 | B2 |
6402679 | Mortier et al. | Jun 2002 | B1 |
6423032 | Parodi | Jul 2002 | B2 |
6425916 | Garrison et al. | Jul 2002 | B1 |
6440164 | DiMatteo et al. | Aug 2002 | B1 |
6454737 | Nita et al. | Sep 2002 | B1 |
6454757 | Nita et al. | Sep 2002 | B1 |
6454799 | Schreck | Sep 2002 | B1 |
6458153 | Bailey et al. | Oct 2002 | B1 |
6461382 | Cao | Oct 2002 | B1 |
6494890 | Shturman et al. | Dec 2002 | B1 |
6494891 | Cornish et al. | Dec 2002 | B1 |
6505080 | Sutton | Jan 2003 | B1 |
6530952 | Vesely | Mar 2003 | B2 |
6540782 | Snyders | Apr 2003 | B1 |
6562067 | Mathis | May 2003 | B2 |
6565588 | Clement et al. | May 2003 | B1 |
6569196 | Vesely | May 2003 | B1 |
6579308 | Jansen et al. | Jun 2003 | B1 |
6582462 | Andersen et al. | Jun 2003 | B1 |
6595912 | Lau et al. | Jul 2003 | B2 |
6605109 | Fiedler | Aug 2003 | B2 |
6616689 | Ainsworth et al. | Sep 2003 | B1 |
6623452 | Chien et al. | Sep 2003 | B2 |
6638288 | Shturman et al. | Oct 2003 | B1 |
6648854 | Patterson et al. | Nov 2003 | B1 |
6689086 | Nita et al. | Feb 2004 | B1 |
6702748 | Nita et al. | Mar 2004 | B1 |
6730118 | Spenser et al. | May 2004 | B2 |
6730121 | Ortiz et al. | May 2004 | B2 |
6746463 | Schwartz | Jun 2004 | B1 |
6811801 | Nguyen et al. | Nov 2004 | B2 |
6818001 | Wulfman et al. | Nov 2004 | B2 |
6843797 | Nash et al. | Jan 2005 | B2 |
6852118 | Shturman et al. | Feb 2005 | B2 |
6855123 | Nita | Feb 2005 | B2 |
6869439 | White et al. | Mar 2005 | B2 |
6951571 | Srivastava | Oct 2005 | B1 |
6986775 | Morales et al. | Jan 2006 | B2 |
7018404 | Holmberg et al. | Mar 2006 | B2 |
7052487 | Cohn et al. | May 2006 | B2 |
7077861 | Spence | Jul 2006 | B2 |
7125420 | Rourke et al. | Oct 2006 | B2 |
7186264 | Liddicoat et al. | Mar 2007 | B2 |
7261732 | Justino | Aug 2007 | B2 |
7296577 | Lashinski et al. | Nov 2007 | B2 |
7381218 | Schreck | Jun 2008 | B2 |
7404824 | Webler et al. | Jul 2008 | B1 |
7442204 | Schwammenthal et al. | Oct 2008 | B2 |
7473275 | Marquez | Jan 2009 | B2 |
7510575 | Spenser et al. | Mar 2009 | B2 |
7585321 | Cribier | Sep 2009 | B2 |
7588582 | Starksen et al. | Sep 2009 | B2 |
7621948 | Herrmann et al. | Nov 2009 | B2 |
7708775 | Rowe et al. | May 2010 | B2 |
7748389 | Salahieh et al. | Jul 2010 | B2 |
7753922 | Starksen | Jul 2010 | B2 |
7753949 | Lamphere et al. | Jul 2010 | B2 |
7803168 | Gifford et al. | Sep 2010 | B2 |
7857845 | Stacchino et al. | Dec 2010 | B2 |
7896915 | Guyenot et al. | Mar 2011 | B2 |
7942928 | Webler et al. | May 2011 | B2 |
8002826 | Seguin | Aug 2011 | B2 |
8052750 | Tuval et al. | Nov 2011 | B2 |
8062355 | Figulla et al. | Nov 2011 | B2 |
8109996 | Stacchino et al. | Feb 2012 | B2 |
8114154 | Righini et al. | Feb 2012 | B2 |
8226711 | Mortier et al. | Jul 2012 | B2 |
8252051 | Chau et al. | Aug 2012 | B2 |
8398704 | Straubinger et al. | Mar 2013 | B2 |
8403981 | Forster et al. | Mar 2013 | B2 |
8403983 | Quadri et al. | Mar 2013 | B2 |
8414643 | Tuval et al. | Apr 2013 | B2 |
8449599 | Chau et al. | May 2013 | B2 |
8496671 | Hausen | Jul 2013 | B1 |
8512252 | Ludomirsky et al. | Aug 2013 | B2 |
8518107 | Tsukashima et al. | Aug 2013 | B2 |
8523883 | Saadat | Sep 2013 | B2 |
8532352 | Ionasec et al. | Sep 2013 | B2 |
8540767 | Zhang | Sep 2013 | B2 |
8545551 | Loulmet | Oct 2013 | B2 |
8551161 | Dolan | Oct 2013 | B2 |
8579788 | Orejola | Nov 2013 | B2 |
8579964 | Lane et al. | Nov 2013 | B2 |
8585755 | Chau et al. | Nov 2013 | B2 |
8597347 | Maurer et al. | Dec 2013 | B2 |
8597348 | Rowe et al. | Dec 2013 | B2 |
8608796 | Matheny | Dec 2013 | B2 |
8608797 | Gross et al. | Dec 2013 | B2 |
8623077 | Cohn | Jan 2014 | B2 |
8628566 | Eberhardt et al. | Jan 2014 | B2 |
8632585 | Seguin et al. | Jan 2014 | B2 |
8632586 | Spenser et al. | Jan 2014 | B2 |
8634935 | Gaudiani | Jan 2014 | B2 |
8647254 | Callas et al. | Feb 2014 | B2 |
8652203 | Quadri et al. | Feb 2014 | B2 |
8652204 | Quill et al. | Feb 2014 | B2 |
8657872 | Seguin | Feb 2014 | B2 |
8672998 | Lichtenstein et al. | Mar 2014 | B2 |
8673001 | Cartledge et al. | Mar 2014 | B2 |
8679176 | Matheny | Mar 2014 | B2 |
8685086 | Navia et al. | Apr 2014 | B2 |
8688234 | Zhu et al. | Apr 2014 | B2 |
8690858 | Machold et al. | Apr 2014 | B2 |
8709074 | Solem et al. | Apr 2014 | B2 |
8712133 | Guhring et al. | Apr 2014 | B2 |
8715160 | Raman et al. | May 2014 | B2 |
8721665 | Oz et al. | May 2014 | B2 |
8721718 | Kassab | May 2014 | B2 |
8740918 | Seguin | Jun 2014 | B2 |
8747460 | Tuval et al. | Jun 2014 | B2 |
8758431 | Orlov et al. | Jun 2014 | B2 |
8758432 | Solem | Jun 2014 | B2 |
8771292 | Allen et al. | Jul 2014 | B2 |
8771345 | Tuval et al. | Jul 2014 | B2 |
8771346 | Tuval et al. | Jul 2014 | B2 |
8777991 | Zarbatany et al. | Jul 2014 | B2 |
8778016 | Janovsky et al. | Jul 2014 | B2 |
8781580 | Hedberg et al. | Jul 2014 | B2 |
8784482 | Rahdert et al. | Jul 2014 | B2 |
8792699 | Guetter et al. | Jul 2014 | B2 |
8795356 | Quadri et al. | Aug 2014 | B2 |
8801779 | Seguin et al. | Aug 2014 | B2 |
8808356 | Braido et al. | Aug 2014 | B2 |
8808366 | Braido et al. | Aug 2014 | B2 |
8812431 | Voigt et al. | Aug 2014 | B2 |
8828043 | Chambers | Sep 2014 | B2 |
8845717 | Khairkhahan et al. | Sep 2014 | B2 |
8845723 | Spence et al. | Sep 2014 | B2 |
8852213 | Gammie et al. | Oct 2014 | B2 |
8852272 | Gross et al. | Oct 2014 | B2 |
8858622 | Machold et al. | Oct 2014 | B2 |
8859724 | Meier et al. | Oct 2014 | B2 |
8864822 | Spence et al. | Oct 2014 | B2 |
8870936 | Rowe | Oct 2014 | B2 |
8870948 | Erzberger et al. | Oct 2014 | B1 |
8870949 | Rowe | Oct 2014 | B2 |
8888843 | Khairkhahan et al. | Nov 2014 | B2 |
8894702 | Quadri et al. | Nov 2014 | B2 |
8900295 | Migliazza et al. | Dec 2014 | B2 |
8926694 | Costello | Jan 2015 | B2 |
8932348 | Solem et al. | Jan 2015 | B2 |
8951285 | Sugimoto et al. | Feb 2015 | B2 |
8961597 | Subramanian et al. | Feb 2015 | B2 |
8968393 | Rothstein | Mar 2015 | B2 |
8968395 | Hauser et al. | Mar 2015 | B2 |
8974445 | Warnking et al. | Mar 2015 | B2 |
8979922 | Jayasinghe et al. | Mar 2015 | B2 |
8979923 | Spence et al. | Mar 2015 | B2 |
8986370 | Annest | Mar 2015 | B2 |
8986376 | Solem | Mar 2015 | B2 |
8992604 | Gross et al. | Mar 2015 | B2 |
9011522 | Annest | Apr 2015 | B2 |
9011523 | Seguin | Apr 2015 | B2 |
9017399 | Gross et al. | Apr 2015 | B2 |
9023098 | Kuehn | May 2015 | B2 |
9023100 | Quadri et al. | May 2015 | B2 |
9050188 | Schweich, Jr et al. | Jun 2015 | B2 |
9056009 | Keränen | Jun 2015 | B2 |
9066800 | Clague et al. | Jun 2015 | B2 |
9078749 | Lutter et al. | Jul 2015 | B2 |
9084676 | Chau et al. | Jul 2015 | B2 |
9095433 | Lutter et al. | Aug 2015 | B2 |
9119713 | Board et al. | Sep 2015 | B2 |
9125742 | Yoganathan et al. | Sep 2015 | B2 |
9132009 | Hacohen et al. | Sep 2015 | B2 |
9138312 | Tuval et al. | Sep 2015 | B2 |
9138313 | McGuckinm, Jr. et al. | Sep 2015 | B2 |
9180005 | Lashinski et al. | Nov 2015 | B1 |
9192466 | Kovalsky et al. | Nov 2015 | B2 |
9192471 | Bolling | Nov 2015 | B2 |
9198756 | Aklog et al. | Dec 2015 | B2 |
9232942 | Seguin et al. | Jan 2016 | B2 |
9232999 | Maurer et al. | Jan 2016 | B2 |
9241790 | Lane et al. | Jan 2016 | B2 |
9248014 | Lane et al. | Feb 2016 | B2 |
9254192 | Lutter et al. | Feb 2016 | B2 |
9271833 | Kim et al. | Mar 2016 | B2 |
9289291 | Gorman, III et al. | Mar 2016 | B2 |
9289297 | Wilson et al. | Mar 2016 | B2 |
9295547 | Costello et al. | Mar 2016 | B2 |
9301836 | Buchbinder et al. | Apr 2016 | B2 |
9308087 | Lane et al. | Apr 2016 | B2 |
9326850 | Venkatasubramanian | May 2016 | B2 |
9339378 | Quadri et al. | May 2016 | B2 |
9339379 | Quadri et al. | May 2016 | B2 |
9339380 | Quadri et al. | May 2016 | B2 |
9339382 | Tabor et al. | May 2016 | B2 |
9358108 | Bortlein et al. | Jun 2016 | B2 |
9387075 | Bortlein et al. | Jul 2016 | B2 |
9387078 | Gross et al. | Jul 2016 | B2 |
9393111 | Ma et al. | Jul 2016 | B2 |
9554906 | Aklog et al. | Jan 2017 | B2 |
9610159 | Christianson et al. | Apr 2017 | B2 |
9629719 | Rothstein et al. | Apr 2017 | B2 |
9675454 | Vidlund et al. | Jun 2017 | B2 |
9681951 | Ratz et al. | Jun 2017 | B2 |
9687342 | Figulla et al. | Jun 2017 | B2 |
9687343 | Bortlein et al. | Jun 2017 | B2 |
9693859 | Braido et al. | Jul 2017 | B2 |
9693862 | Campbell et al. | Jul 2017 | B2 |
9694121 | Alexander et al. | Jul 2017 | B2 |
9700409 | Braido et al. | Jul 2017 | B2 |
9700411 | Klima et al. | Jul 2017 | B2 |
9730791 | Ratz et al. | Aug 2017 | B2 |
9730792 | Lutter et al. | Aug 2017 | B2 |
9730794 | Carpentier et al. | Aug 2017 | B2 |
9744036 | Duffy et al. | Aug 2017 | B2 |
9750605 | Ganesan et al. | Sep 2017 | B2 |
9750606 | Ganesan et al. | Sep 2017 | B2 |
9750607 | Ganesan et al. | Sep 2017 | B2 |
9763657 | Hacohen et al. | Sep 2017 | B2 |
9763658 | Eigler et al. | Sep 2017 | B2 |
9763782 | Solem et al. | Sep 2017 | B2 |
9770328 | Macoviak et al. | Sep 2017 | B2 |
9827092 | Vidlund et al. | Nov 2017 | B2 |
9827101 | Solem et al. | Nov 2017 | B2 |
9833313 | Board et al. | Dec 2017 | B2 |
9833315 | Vidlund et al. | Dec 2017 | B2 |
9839511 | Ma et al. | Dec 2017 | B2 |
9844435 | Eidenschink | Dec 2017 | B2 |
9848880 | Coleman et al. | Dec 2017 | B2 |
9848983 | Lashinski et al. | Dec 2017 | B2 |
9861477 | Backus et al. | Jan 2018 | B2 |
9861480 | Zakai et al. | Jan 2018 | B2 |
9895221 | Vidlund et al. | Feb 2018 | B2 |
10080659 | Zentgraf et al. | Sep 2018 | B1 |
10085835 | Thambar et al. | Oct 2018 | B2 |
10111747 | Gifford, III | Oct 2018 | B2 |
10123874 | Khairkhahan et al. | Nov 2018 | B2 |
10238490 | Gifford, III | Mar 2019 | B2 |
20010021872 | Bailey et al. | Sep 2001 | A1 |
20010049492 | Frazier et al. | Dec 2001 | A1 |
20020007219 | Merrill et al. | Jan 2002 | A1 |
20020013571 | Goldfarb et al. | Jan 2002 | A1 |
20020072792 | Burgermeister et al. | Jun 2002 | A1 |
20020077627 | Johnson et al. | Jun 2002 | A1 |
20020082637 | Lumauig | Jun 2002 | A1 |
20020099439 | Schwartz et al. | Jul 2002 | A1 |
20020138138 | Yang | Sep 2002 | A1 |
20020151970 | Garrison et al. | Oct 2002 | A1 |
20020173841 | Ortiz et al. | Nov 2002 | A1 |
20030078653 | Vesely | Apr 2003 | A1 |
20030120340 | Liska et al. | Jun 2003 | A1 |
20030139689 | Shturman et al. | Jul 2003 | A1 |
20040006358 | Wulfman et al. | Jan 2004 | A1 |
20040039412 | Isshiki et al. | Feb 2004 | A1 |
20040044350 | Martin et al. | Mar 2004 | A1 |
20040057955 | O'Brien et al. | Mar 2004 | A1 |
20040082910 | Constantz et al. | Apr 2004 | A1 |
20040092858 | Wilson et al. | May 2004 | A1 |
20040092962 | Thornton et al. | May 2004 | A1 |
20040092989 | Wilson et al. | May 2004 | A1 |
20040106989 | Wilson et al. | Jun 2004 | A1 |
20040117009 | Cali et al. | Jun 2004 | A1 |
20040122510 | Sarac | Jun 2004 | A1 |
20040127979 | Wilson et al. | Jul 2004 | A1 |
20040127982 | Machold et al. | Jul 2004 | A1 |
20040186558 | Pavcnik et al. | Sep 2004 | A1 |
20040199191 | Schwartz | Oct 2004 | A1 |
20040220593 | Greenhalgh | Nov 2004 | A1 |
20040230117 | Tosaya et al. | Nov 2004 | A1 |
20040230212 | Wulfman | Nov 2004 | A1 |
20040230213 | Wulfman | Nov 2004 | A1 |
20040243162 | Wulfman | Nov 2004 | A1 |
20050007219 | Ma et al. | Jan 2005 | A1 |
20050075662 | Ma et al. | Jan 2005 | A1 |
20050075720 | Pedersen et al. | Apr 2005 | A1 |
20050075727 | Wheatley | Apr 2005 | A1 |
20050137682 | Nguyen et al. | Apr 2005 | A1 |
20050096647 | Steinke et al. | May 2005 | A1 |
20050107661 | Lau et al. | May 2005 | A1 |
20050137690 | Justino | Jun 2005 | A1 |
20050137691 | Salahieh et al. | Jun 2005 | A1 |
20050137695 | Salahieh et al. | Jun 2005 | A1 |
20050137697 | Salahieh et al. | Jun 2005 | A1 |
20050137698 | Salahieh et al. | Jun 2005 | A1 |
20050137700 | Salahieh et al. | Jun 2005 | A1 |
20050137701 | Spence et al. | Jun 2005 | A1 |
20050137702 | Haug et al. | Jun 2005 | A1 |
20050267523 | Salahieh et al. | Jun 2005 | A1 |
20050228477 | Grainger et al. | Oct 2005 | A1 |
20050273135 | Chanduszko et al. | Dec 2005 | A1 |
20060015178 | Moaddeb et al. | Jan 2006 | A1 |
20060058872 | Salahieh et al. | Mar 2006 | A1 |
20060106456 | Machold et al. | May 2006 | A9 |
20060149360 | Schwammenthal et al. | Jul 2006 | A1 |
20060167543 | Bailey et al. | Jul 2006 | A1 |
20060195183 | Schwammenthal et al. | Jul 2006 | A1 |
20060253191 | Navia et al. | Aug 2006 | A1 |
20060287719 | Salahieh et al. | Nov 2006 | A1 |
20070056346 | Spencer et al. | Mar 2007 | A1 |
20070061010 | Hauser et al. | Mar 2007 | A1 |
20070073391 | Bourang et al. | Mar 2007 | A1 |
20070078302 | Ortiz et al. | Apr 2007 | A1 |
20070088431 | Bourang et al. | Apr 2007 | A1 |
20070142906 | Figulla et al. | Jun 2007 | A1 |
20070173932 | Cali et al. | Jul 2007 | A1 |
20080039935 | Buch et al. | Feb 2008 | A1 |
20080071369 | Tuval et al. | Mar 2008 | A1 |
20080082166 | Styrc et al. | Apr 2008 | A1 |
20080103586 | Styrc et al. | May 2008 | A1 |
20080140189 | Nguyen et al. | Jun 2008 | A1 |
20080140190 | Macoviak et al. | Jun 2008 | A1 |
20080208332 | Lamphere et al. | Aug 2008 | A1 |
20080221672 | Lamphere et al. | Sep 2008 | A1 |
20080234728 | Starksen et al. | Sep 2008 | A1 |
20080243245 | Thambar et al. | Oct 2008 | A1 |
20080243246 | Ryan et al. | Oct 2008 | A1 |
20090043381 | Macoviak | Feb 2009 | A1 |
20090054969 | Salahieh et al. | Feb 2009 | A1 |
20090076586 | Hauser et al. | Mar 2009 | A1 |
20090076598 | Salahieh et al. | Mar 2009 | A1 |
20090093670 | Annest et al. | Apr 2009 | A1 |
20090118744 | Wells et al. | May 2009 | A1 |
20090149872 | Gross et al. | Jun 2009 | A1 |
20090157174 | Yoganathan et al. | Jun 2009 | A1 |
20090164006 | Seguin et al. | Jun 2009 | A1 |
20090198315 | Boudjemline | Aug 2009 | A1 |
20090216312 | Straubinger et al. | Aug 2009 | A1 |
20090240320 | Tuval et al. | Sep 2009 | A1 |
20090259292 | Bonhoeffer | Oct 2009 | A1 |
20090259306 | Rowe | Oct 2009 | A1 |
20090264997 | Salahieh et al. | Oct 2009 | A1 |
20090276040 | Rowe et al. | Nov 2009 | A1 |
20090281609 | Benichou et al. | Nov 2009 | A1 |
20090281618 | Hill et al. | Nov 2009 | A1 |
20090292350 | Eberhardt et al. | Nov 2009 | A1 |
20090306768 | Quadri | Dec 2009 | A1 |
20090319037 | Rowe et al. | Dec 2009 | A1 |
20090319038 | Gurskis et al. | Dec 2009 | A1 |
20100016958 | St. Goar et al. | Jan 2010 | A1 |
20100023115 | Robaina et al. | Jan 2010 | A1 |
20100023117 | Yoganathan et al. | Jan 2010 | A1 |
20100030330 | Bobo et al. | Feb 2010 | A1 |
20100049313 | Alon et al. | Feb 2010 | A1 |
20100063586 | Hasenkam et al. | Mar 2010 | A1 |
20100076548 | Konno | Mar 2010 | A1 |
20100082094 | Quadri et al. | Apr 2010 | A1 |
20100094411 | Tuval et al. | Apr 2010 | A1 |
20100121436 | Tuval et al. | May 2010 | A1 |
20100185275 | Richter et al. | Jul 2010 | A1 |
20100217382 | Chau et al. | Aug 2010 | A1 |
20100249915 | Zhang | Sep 2010 | A1 |
20100249923 | Alkhatib et al. | Sep 2010 | A1 |
20100298929 | Thornton et al. | Nov 2010 | A1 |
20100298931 | Quadri et al. | Nov 2010 | A1 |
20100312333 | Navia et al. | Dec 2010 | A1 |
20100324554 | Gifford et al. | Dec 2010 | A1 |
20110004296 | Lutter et al. | Jan 2011 | A1 |
20110015722 | Hauser et al. | Jan 2011 | A1 |
20110022166 | Dahlgren et al. | Jan 2011 | A1 |
20110029071 | Zlotnick et al. | Feb 2011 | A1 |
20110029072 | Gabbay | Feb 2011 | A1 |
20110040374 | Goetz et al. | Feb 2011 | A1 |
20110040375 | Letac et al. | Feb 2011 | A1 |
20110066231 | Cartledge et al. | Mar 2011 | A1 |
20110066233 | Thornton et al. | Mar 2011 | A1 |
20110112632 | Chau et al. | May 2011 | A1 |
20110137397 | Chau et al. | Jun 2011 | A1 |
20110137409 | Yang et al. | Jun 2011 | A1 |
20110137410 | Hacohen | Jun 2011 | A1 |
20110153008 | Marchand et al. | Jun 2011 | A1 |
20110172784 | Richter et al. | Jul 2011 | A1 |
20110184512 | Webler et al. | Jul 2011 | A1 |
20110208293 | Tabor | Aug 2011 | A1 |
20110224785 | Hacohen | Sep 2011 | A1 |
20110319988 | Schankereli et al. | Dec 2011 | A1 |
20110319990 | Macoviak et al. | Dec 2011 | A1 |
20120022639 | Hacohen et al. | Jan 2012 | A1 |
20120035703 | Lutter et al. | Feb 2012 | A1 |
20120035713 | Lutter et al. | Feb 2012 | A1 |
20120053680 | Bolling et al. | Mar 2012 | A1 |
20120053682 | Kovalsky et al. | Mar 2012 | A1 |
20120078347 | Braido et al. | Mar 2012 | A1 |
20120078360 | Rafiee | Mar 2012 | A1 |
20120101571 | Thambar et al. | Apr 2012 | A1 |
20120165930 | Gifford, III et al. | Jun 2012 | A1 |
20120179239 | Quadri | Jul 2012 | A1 |
20120179244 | Schankereli et al. | Jul 2012 | A1 |
20120203336 | Annest | Aug 2012 | A1 |
20120283824 | Lutter et al. | Nov 2012 | A1 |
20130079873 | Migliazza et al. | Mar 2013 | A1 |
20130172978 | Vidlund et al. | Jul 2013 | A1 |
20130190860 | Sundt, III | Jul 2013 | A1 |
20130190861 | Chau et al. | Jul 2013 | A1 |
20130197354 | Maschke et al. | Aug 2013 | A1 |
20130197630 | Azarnoush | Aug 2013 | A1 |
20130204356 | Dwork et al. | Aug 2013 | A1 |
20130204358 | Matheny | Aug 2013 | A1 |
20130204361 | Adams et al. | Aug 2013 | A1 |
20130226289 | Shaolian et al. | Aug 2013 | A1 |
20130226290 | Yellin et al. | Aug 2013 | A1 |
20130231735 | Deem et al. | Sep 2013 | A1 |
20130238089 | Lichtenstein et al. | Sep 2013 | A1 |
20130244927 | Lal et al. | Sep 2013 | A1 |
20130253641 | Lattouf | Sep 2013 | A1 |
20130253642 | Brecker | Sep 2013 | A1 |
20130253643 | Rolando et al. | Sep 2013 | A1 |
20130259337 | Guhring et al. | Oct 2013 | A1 |
20130261737 | Costello | Oct 2013 | A1 |
20130261738 | Calgue et al. | Oct 2013 | A1 |
20130261739 | Kuehn | Oct 2013 | A1 |
20130261741 | Accola | Oct 2013 | A1 |
20130268066 | Rowe | Oct 2013 | A1 |
20130274870 | Lombardi et al. | Oct 2013 | A1 |
20130282059 | Ketai et al. | Oct 2013 | A1 |
20130282060 | Tuval | Oct 2013 | A1 |
20130282110 | Schweich, Jr. et al. | Oct 2013 | A1 |
20130289642 | Hedberg et al. | Oct 2013 | A1 |
20130289717 | Solem | Oct 2013 | A1 |
20130289718 | Tsukashima et al. | Oct 2013 | A1 |
20130296851 | Boronyak et al. | Nov 2013 | A1 |
20130296999 | Burriesci et al. | Nov 2013 | A1 |
20130304180 | Green et al. | Nov 2013 | A1 |
20130304181 | Green et al. | Nov 2013 | A1 |
20130304197 | Buchbinder et al. | Nov 2013 | A1 |
20130304198 | Solem | Nov 2013 | A1 |
20130304200 | McLean et al. | Nov 2013 | A1 |
20130309292 | Andersen | Nov 2013 | A1 |
20130310436 | Lowes et al. | Nov 2013 | A1 |
20130310925 | Eliasen et al. | Nov 2013 | A1 |
20130310928 | Morriss et al. | Nov 2013 | A1 |
20130317603 | McLean et al. | Nov 2013 | A1 |
20130325110 | Khalil et al. | Dec 2013 | A1 |
20130325114 | McLean et al. | Dec 2013 | A1 |
20130331864 | Jelich et al. | Dec 2013 | A1 |
20130338684 | Hausen | Dec 2013 | A1 |
20130338763 | Rowe et al. | Dec 2013 | A1 |
20130345797 | Dahlgren et al. | Dec 2013 | A1 |
20130345803 | Bergheim, III | Dec 2013 | A1 |
20140005778 | Buchbinder et al. | Jan 2014 | A1 |
20140018906 | Rafiee | Jan 2014 | A1 |
20140018913 | Cartledge et al. | Jan 2014 | A1 |
20140023261 | Watanabe et al. | Jan 2014 | A1 |
20140025164 | Montorfano et al. | Jan 2014 | A1 |
20140031928 | Murphy et al. | Jan 2014 | A1 |
20140046219 | Sauter et al. | Feb 2014 | A1 |
20140046436 | Kheradvar | Feb 2014 | A1 |
20140052237 | Lane et al. | Feb 2014 | A1 |
20140052240 | Zhang | Feb 2014 | A1 |
20140056906 | Yue et al. | Feb 2014 | A1 |
20140066895 | Kipperman | Mar 2014 | A1 |
20140067048 | Chau et al. | Mar 2014 | A1 |
20140067052 | Chau et al. | Mar 2014 | A1 |
20140067054 | Chau et al. | Mar 2014 | A1 |
20140088071 | Nakai et al. | Mar 2014 | A1 |
20140088680 | Costello et al. | Mar 2014 | A1 |
20140088693 | Seguin et al. | Mar 2014 | A1 |
20140088695 | Figulla et al. | Mar 2014 | A1 |
20140128965 | Figulla et al. | Mar 2014 | A1 |
20140094906 | Spence et al. | Apr 2014 | A1 |
20140107775 | Hjelle et al. | Apr 2014 | A1 |
20140114404 | Gammie et al. | Apr 2014 | A1 |
20140114407 | Rajamannan | Apr 2014 | A1 |
20140135913 | Spence et al. | Apr 2014 | A1 |
20140163652 | Hjelle et al. | Apr 2014 | A1 |
20140163668 | Gammie et al. | Apr 2014 | A1 |
20140172076 | Rajamannan | Apr 2014 | A1 |
20140121763 | Duffy et al. | May 2014 | A1 |
20140172084 | Duffy et al. | May 2014 | A1 |
20140172085 | Rafiee | May 2014 | A1 |
20140172086 | Lichtenstein et al. | May 2014 | A1 |
20140179993 | Witzel et al. | Jun 2014 | A1 |
20140180401 | Rafiee | Jun 2014 | A1 |
20140188108 | Jonsson et al. | Jun 2014 | A1 |
20140188215 | Callas et al. | Jun 2014 | A1 |
20140194920 | Quadri et al. | Jun 2014 | A1 |
20140194976 | Quadri et al. | Jun 2014 | A1 |
20140200397 | Alexander et al. | Jun 2014 | A1 |
20140200649 | Quill et al. | Jun 2014 | A1 |
20140200657 | Goodine et al. | Jul 2014 | A1 |
20140200662 | Hlavka et al. | Jul 2014 | A1 |
20140214159 | Krahbichler | Jul 2014 | A1 |
20140219524 | Starksen et al. | Jul 2014 | A1 |
20140222040 | Raman et al. | Jul 2014 | A1 |
20140222138 | Essinger et al. | Jul 2014 | A1 |
20140228942 | Maurer et al. | Jul 2014 | A1 |
20140228946 | Eftel et al. | Jul 2014 | A1 |
20140242086 | Lal et al. | Aug 2014 | A1 |
20140243860 | Morris et al. | Aug 2014 | A1 |
20140243954 | Shannon | Aug 2014 | A1 |
20140243964 | Venkatasubramanian | Aug 2014 | A1 |
20140249621 | Eidenschink | Sep 2014 | A1 |
20140257101 | Gaudiani | Sep 2014 | A1 |
20140257466 | Board et al. | Sep 2014 | A1 |
20140257467 | Lane et al. | Sep 2014 | A1 |
20140257473 | Rajamannan | Sep 2014 | A1 |
20140257475 | Gross et al. | Sep 2014 | A1 |
20140275757 | Goodwin et al. | Sep 2014 | A1 |
20140276395 | Wilson et al. | Sep 2014 | A1 |
20140276609 | Magee et al. | Sep 2014 | A1 |
20140276782 | Paskar | Sep 2014 | A1 |
20140276971 | Kovach | Sep 2014 | A1 |
20140277119 | Akpinar | Sep 2014 | A1 |
20140277390 | Ratz et al. | Sep 2014 | A1 |
20140277404 | Wilson et al. | Sep 2014 | A1 |
20140277405 | Wilson et al. | Sep 2014 | A1 |
20140277406 | Arcidi | Sep 2014 | A1 |
20140277407 | Dale et al. | Sep 2014 | A1 |
20140277408 | Folan | Sep 2014 | A1 |
20140277409 | Bortlein et al. | Sep 2014 | A1 |
20140277410 | Bortlein et al. | Sep 2014 | A1 |
20140277411 | Bortlein et al. | Sep 2014 | A1 |
20140277412 | Bortlein et al. | Sep 2014 | A1 |
20140277420 | Migliazza et al. | Sep 2014 | A1 |
20140277422 | Ratz et al. | Sep 2014 | A1 |
20140288480 | Zimmerman et al. | Sep 2014 | A1 |
20140296878 | Oz et al. | Oct 2014 | A1 |
20140296969 | Tegels et al. | Oct 2014 | A1 |
20140296970 | Ekvall et al. | Oct 2014 | A1 |
20140296971 | Tegels et al. | Oct 2014 | A1 |
20140296975 | Tegels et al. | Oct 2014 | A1 |
20140303719 | Cox et al. | Oct 2014 | A1 |
20140303721 | Fung et al. | Oct 2014 | A1 |
20140309727 | Lamelas et al. | Oct 2014 | A1 |
20140309730 | Alon et al. | Oct 2014 | A1 |
20140309731 | Quadri et al. | Oct 2014 | A1 |
20140309732 | Solem | Oct 2014 | A1 |
20140316516 | Vidlund et al. | Oct 2014 | A1 |
20140324164 | Gross et al. | Oct 2014 | A1 |
20140358222 | Gorman, III et al. | Dec 2014 | A1 |
20140358224 | Tegels et al. | Dec 2014 | A1 |
20140364944 | Lutter et al. | Dec 2014 | A1 |
20140371843 | Wilson et al. | Dec 2014 | A1 |
20140371844 | Dale et al. | Dec 2014 | A1 |
20140371846 | Wilson et al. | Dec 2014 | A1 |
20140379074 | Spence et al. | Dec 2014 | A1 |
20140379076 | Vidlund et al. | Dec 2014 | A1 |
20150005874 | Vidlund et al. | Jan 2015 | A1 |
20150005875 | Tuval et al. | Jan 2015 | A1 |
20150025623 | Granada et al. | Jan 2015 | A1 |
20150032127 | Gammie et al. | Jan 2015 | A1 |
20150045878 | Rowe | Feb 2015 | A1 |
20150066140 | Quadri et al. | Mar 2015 | A1 |
20150094802 | Buchbinder et al. | Apr 2015 | A1 |
20150094803 | Navia | Apr 2015 | A1 |
20150100116 | Mohl et al. | Apr 2015 | A1 |
20150112427 | Schweich, Jr. et al. | Apr 2015 | A1 |
20150112429 | Khairkhahan et al. | Apr 2015 | A1 |
20150112433 | Schweich, Jr. et al. | Apr 2015 | A1 |
20150119978 | Tegels et al. | Apr 2015 | A1 |
20150119981 | Khairkhahan et al. | Apr 2015 | A1 |
20150119982 | Quill et al. | Apr 2015 | A1 |
20150127091 | Cecere et al. | May 2015 | A1 |
20150127096 | Rowe et al. | May 2015 | A1 |
20150142101 | Coleman et al. | May 2015 | A1 |
20150142103 | Vidlund | May 2015 | A1 |
20150142105 | Bolling et al. | May 2015 | A1 |
20150150678 | Brecker | Jun 2015 | A1 |
20150157458 | Thambar et al. | Jun 2015 | A1 |
20150157459 | Macoviak et al. | Jun 2015 | A1 |
20150164637 | Khairkhahan et al. | Jun 2015 | A1 |
20150164641 | Annest | Jun 2015 | A1 |
20150173897 | Raanani et al. | Jun 2015 | A1 |
20150173898 | Drasler et al. | Jun 2015 | A1 |
20150173900 | Hauser et al. | Jun 2015 | A1 |
20150190229 | Seguin | Jul 2015 | A1 |
20150196390 | Ma et al. | Jul 2015 | A1 |
20150196393 | Vidlund et al. | Jul 2015 | A1 |
20150202043 | Zakai et al. | Jul 2015 | A1 |
20150209137 | Quadri et al. | Jul 2015 | A1 |
20150209139 | Granada et al. | Jul 2015 | A1 |
20150216655 | Lane et al. | Aug 2015 | A1 |
20150216661 | Hacohen et al. | Aug 2015 | A1 |
20150223802 | Tegzes | Aug 2015 | A1 |
20150223934 | Vidlund et al. | Aug 2015 | A1 |
20150223935 | Subramanian et al. | Aug 2015 | A1 |
20150230920 | Alfieri et al. | Aug 2015 | A1 |
20150230921 | Chau et al. | Aug 2015 | A1 |
20150238312 | Lashinski | Aug 2015 | A1 |
20150238313 | Spence et al. | Aug 2015 | A1 |
20150250590 | Gries et al. | Sep 2015 | A1 |
20150257877 | Hernandez | Sep 2015 | A1 |
20150257878 | Lane et al. | Sep 2015 | A1 |
20150257879 | Bortlein et al. | Sep 2015 | A1 |
20150257881 | Bortlein et al. | Sep 2015 | A1 |
20150257882 | Bortlein et al. | Sep 2015 | A1 |
20150272737 | Dale et al. | Oct 2015 | A1 |
20150305861 | Annest | Oct 2015 | A1 |
20150305864 | Quadri et al. | Oct 2015 | A1 |
20150313739 | Hummen et al. | Nov 2015 | A1 |
20150320553 | Chau et al. | Nov 2015 | A1 |
20150327999 | Board et al. | Nov 2015 | A1 |
20150328000 | Ratz et al. | Nov 2015 | A1 |
20150342733 | Alkhatib et al. | Dec 2015 | A1 |
20150351906 | Hammer et al. | Dec 2015 | A1 |
20150351908 | Keranen et al. | Dec 2015 | A1 |
20150359628 | Keranen | Dec 2015 | A1 |
20150359629 | Ganesan et al. | Dec 2015 | A1 |
20150359631 | Sheahan et al. | Dec 2015 | A1 |
20150366666 | Khairkhahan et al. | Dec 2015 | A1 |
20150374495 | Ruyra Baliarda et al. | Dec 2015 | A1 |
20160000983 | Mohl et al. | Jan 2016 | A1 |
20160015513 | Lashinski et al. | Jan 2016 | A1 |
20160015514 | Lashinski et al. | Jan 2016 | A1 |
20160015515 | Lashinski et al. | Jan 2016 | A1 |
20160015543 | Perouse et al. | Jan 2016 | A1 |
20160030171 | Quijano et al. | Feb 2016 | A1 |
20160038246 | Wang et al. | Feb 2016 | A1 |
20160038280 | Morriss et al. | Feb 2016 | A1 |
20160038283 | Divekar et al. | Feb 2016 | A1 |
20160038286 | Yellin et al. | Feb 2016 | A1 |
20160074160 | Christianson et al. | Mar 2016 | A1 |
20160106539 | Buchbinder et al. | Apr 2016 | A1 |
20160113764 | Sheahan et al. | Apr 2016 | A1 |
20160113765 | Ganesan et al. | Apr 2016 | A1 |
20160113766 | Ganesan et al. | Apr 2016 | A1 |
20160113768 | Ganesan et al. | Apr 2016 | A1 |
20160120643 | Kupumbati | May 2016 | A1 |
20160143730 | Kheradvar | May 2016 | A1 |
20160151154 | Gorman, III et al. | Jun 2016 | A1 |
20160151156 | Seguin et al. | Jun 2016 | A1 |
20160151552 | Solem | Jun 2016 | A1 |
20160157999 | Lane et al. | Jun 2016 | A1 |
20160158000 | Granada et al. | Jun 2016 | A1 |
20160158001 | Wallace et al. | Jun 2016 | A1 |
20160158002 | Wallace et al. | Jun 2016 | A1 |
20160158003 | Wallace et al. | Jun 2016 | A1 |
20160184095 | Spence et al. | Jun 2016 | A1 |
20160206280 | Vidlund et al. | Jul 2016 | A1 |
20160206424 | Al-jilaihawi et al. | Jul 2016 | A1 |
20160262881 | Schankereli et al. | Sep 2016 | A1 |
20160278920 | Braido et al. | Sep 2016 | A1 |
20160317290 | Chau et al. | Nov 2016 | A1 |
20170079790 | Vidlund et al. | Mar 2017 | A1 |
20170100248 | Tegels et al. | Apr 2017 | A1 |
20170100250 | Marsot et al. | Apr 2017 | A1 |
20170119526 | Luong et al. | May 2017 | A1 |
20170125208 | Kikuiri et al. | May 2017 | A1 |
20170128198 | Cartledge et al. | May 2017 | A1 |
20170128205 | Tamir et al. | May 2017 | A1 |
20170128206 | Rafiee et al. | May 2017 | A1 |
20170128208 | Christianson et al. | May 2017 | A1 |
20170156860 | Lashinski | Jun 2017 | A1 |
20170165054 | Benson et al. | Jun 2017 | A1 |
20170165055 | Hauser et al. | Jun 2017 | A1 |
20170165064 | Nyuli et al. | Jun 2017 | A1 |
20170172737 | Kuetting et al. | Jun 2017 | A1 |
20170181851 | Annest | Jun 2017 | A1 |
20170189177 | Schweich, Jr. et al. | Jul 2017 | A1 |
20170189179 | Ratz et al. | Jul 2017 | A1 |
20170189180 | Alkhatib | Jul 2017 | A1 |
20170189181 | Alkhatib et al. | Jul 2017 | A1 |
20170196688 | Christianson et al. | Jul 2017 | A1 |
20170231762 | Quadri et al. | Aug 2017 | A1 |
20170231763 | Yellin et al. | Aug 2017 | A1 |
20170258585 | Marquez et al. | Sep 2017 | A1 |
20170266001 | Vidlund et al. | Sep 2017 | A1 |
20170281345 | Yang et al. | Oct 2017 | A1 |
20170290659 | Ulmer et al. | Oct 2017 | A1 |
20170296338 | Campbell et al. | Oct 2017 | A1 |
20170296339 | Thambar et al. | Oct 2017 | A1 |
20170319333 | Tegels et al. | Nov 2017 | A1 |
20170325941 | Wallace et al. | Nov 2017 | A1 |
20170325945 | Dale et al. | Nov 2017 | A1 |
20170325948 | Wallace et al. | Nov 2017 | A1 |
20170333186 | Spargias | Nov 2017 | A1 |
20170333188 | Carpentier et al. | Nov 2017 | A1 |
20170340440 | Ratz et al. | Nov 2017 | A1 |
20170348098 | Rowe et al. | Dec 2017 | A1 |
20170348100 | Lane et al. | Dec 2017 | A1 |
20170354496 | Quadri et al. | Dec 2017 | A1 |
20170354497 | Quadri et al. | Dec 2017 | A1 |
20170354499 | Granada et al. | Dec 2017 | A1 |
20170360426 | Hacohen et al. | Dec 2017 | A1 |
20170360549 | Lashinski et al. | Dec 2017 | A1 |
20170360558 | Ma | Dec 2017 | A1 |
20170360585 | White | Dec 2017 | A1 |
20190029812 | Gifford, III | Jan 2019 | A1 |
Number | Date | Country |
---|---|---|
1440261 | Sep 2003 | CN |
101076290 | Nov 2007 | CN |
101291637 | Oct 2008 | CN |
101588771 | Nov 2009 | CN |
102065777 | May 2011 | CN |
102985031 | Mar 2013 | CN |
202821715 | Mar 2013 | CN |
103491900 | Jan 2014 | CN |
104055600 | Sep 2014 | CN |
104203158 | Dec 2014 | CN |
104768500 | Jul 2015 | CN |
104799974 | Jul 2015 | CN |
19605042 | Jan 1998 | DE |
102006052564 | Dec 2007 | DE |
0186104 | Jul 1986 | EP |
1512383 | Mar 2005 | EP |
1545371 | Jun 2005 | EP |
1551274 | Jul 2005 | EP |
1629794 | Mar 2006 | EP |
1646332 | Apr 2006 | EP |
1702247 | Sep 2006 | EP |
1734903 | Dec 2006 | EP |
1891914 | Feb 2008 | EP |
2026280 | Feb 2009 | EP |
2037829 | Mar 2009 | EP |
2081519 | Jul 2009 | EP |
2111190 | Oct 2009 | EP |
2142143 | Jan 2010 | EP |
2167742 | Mar 2010 | EP |
2278944 | Feb 2011 | EP |
2306821 | Apr 2011 | EP |
2327429 | Jun 2011 | EP |
2400924 | Jan 2012 | EP |
2400926 | Jan 2012 | EP |
2410947 | Feb 2012 | EP |
2444031 | Apr 2012 | EP |
2488126 | Aug 2012 | EP |
2509538 | Oct 2012 | EP |
2549955 | Jan 2013 | EP |
2549956 | Jan 2013 | EP |
2566416 | Mar 2013 | EP |
2586492 | May 2013 | EP |
2618784 | Jul 2013 | EP |
2623068 | Aug 2013 | EP |
2626013 | Aug 2013 | EP |
2629699 | Aug 2013 | EP |
2633457 | Sep 2013 | EP |
2637659 | Sep 2013 | EP |
2641569 | Sep 2013 | EP |
2644158 | Oct 2013 | EP |
2654624 | Oct 2013 | EP |
2656794 | Oct 2013 | EP |
2656795 | Oct 2013 | EP |
2656796 | Oct 2013 | EP |
2667823 | Dec 2013 | EP |
2670358 | Dec 2013 | EP |
2676640 | Dec 2013 | EP |
2688041 | Jan 2014 | EP |
2695586 | Feb 2014 | EP |
2697721 | Feb 2014 | EP |
2713953 | Apr 2014 | EP |
2714068 | Apr 2014 | EP |
2723272 | Apr 2014 | EP |
2723273 | Apr 2014 | EP |
2723277 | Apr 2014 | EP |
2739214 | Jun 2014 | EP |
2741711 | Jun 2014 | EP |
2750630 | Jul 2014 | EP |
2750631 | Jul 2014 | EP |
2755562 | Jul 2014 | EP |
2755602 | Jul 2014 | EP |
2757962 | Jul 2014 | EP |
2777616 | Sep 2014 | EP |
2777617 | Sep 2014 | EP |
2782523 | Oct 2014 | EP |
2785282 | Oct 2014 | EP |
2786817 | Oct 2014 | EP |
2790609 | Oct 2014 | EP |
2793751 | Oct 2014 | EP |
2809263 | Dec 2014 | EP |
2810620 | Dec 2014 | EP |
2814428 | Dec 2014 | EP |
2814429 | Dec 2014 | EP |
2819617 | Jan 2015 | EP |
2819618 | Jan 2015 | EP |
2819619 | Jan 2015 | EP |
2416739 | Feb 2015 | EP |
2833836 | Feb 2015 | EP |
2838475 | Feb 2015 | EP |
2839815 | Feb 2015 | EP |
2844190 | Mar 2015 | EP |
2849680 | Mar 2015 | EP |
2849681 | Mar 2015 | EP |
2852354 | Apr 2015 | EP |
2870933 | May 2015 | EP |
2873011 | May 2015 | EP |
2875797 | May 2015 | EP |
2760375 | Jun 2015 | EP |
2882374 | Jun 2015 | EP |
2886082 | Jun 2015 | EP |
2886083 | Jun 2015 | EP |
2886084 | Jun 2015 | EP |
2895111 | Jul 2015 | EP |
2901966 | Aug 2015 | EP |
2907479 | Aug 2015 | EP |
2945572 | Nov 2015 | EP |
2948094 | Dec 2015 | EP |
2948102 | Dec 2015 | EP |
2964152 | Jan 2016 | EP |
2967859 | Jan 2016 | EP |
2967860 | Jan 2016 | EP |
2967866 | Jan 2016 | EP |
2968847 | Jan 2016 | EP |
2981208 | Feb 2016 | EP |
2982336 | Feb 2016 | EP |
2999433 | Mar 2016 | EP |
3003187 | Apr 2016 | EP |
3003219 | Apr 2016 | EP |
3003220 | Apr 2016 | EP |
3010447 | Apr 2016 | EP |
3013281 | May 2016 | EP |
3017792 | May 2016 | EP |
3021792 | May 2016 | EP |
3023117 | May 2016 | EP |
3027143 | Jun 2016 | EP |
3033048 | Jun 2016 | EP |
3037064 | Jun 2016 | EP |
3079633 | Oct 2016 | EP |
3229736 | Nov 2016 | EP |
2470119 | May 2017 | EP |
2999436 | May 2017 | EP |
2419050 | Jun 2017 | EP |
3184081 | Jun 2017 | EP |
3191027 | Jul 2017 | EP |
2611389 | Aug 2017 | EP |
3082656 | Aug 2017 | EP |
3206628 | Aug 2017 | EP |
2010103 | Sep 2017 | EP |
2509538 | Sep 2017 | EP |
3223751 | Oct 2017 | EP |
3027144 | Nov 2017 | EP |
3110368 | Nov 2017 | EP |
3110369 | Nov 2017 | EP |
3132773 | Nov 2017 | EP |
3245980 | Nov 2017 | EP |
3250154 | Dec 2017 | EP |
3256077 | Dec 2017 | EP |
3258883 | Dec 2017 | EP |
3273910 | Jan 2018 | EP |
H06504516 | May 1994 | JP |
H10258124 | Sep 1998 | JP |
2002509756 | Apr 2002 | JP |
2005280917 | Oct 2005 | JP |
2008528117 | Jul 2008 | JP |
2008541863 | Nov 2008 | JP |
2009195712 | Sep 2009 | JP |
2010518947 | Jun 2010 | JP |
5219518 | Jun 2013 | JP |
WO1992017118 | Oct 1992 | WO |
WO1995016407 | Jun 1995 | WO |
WO1999004730 | Feb 1999 | WO |
WO1999039648 | Aug 1999 | WO |
WO1999049799 | Oct 1999 | WO |
WO2001010343 | Feb 2001 | WO |
WO2002003892 | Jan 2002 | WO |
WO2002028421 | Apr 2002 | WO |
WO2002039908 | May 2002 | WO |
WO2003043685 | May 2003 | WO |
WO2004084746 | Oct 2004 | WO |
WO2004093728 | Nov 2004 | WO |
WO2004096097 | Nov 2004 | WO |
WO2004112657 | Dec 2004 | WO |
WO2005002466 | Jan 2005 | WO |
WO2005007219 | Jan 2005 | WO |
WO2005009285 | Feb 2005 | WO |
WO2005009506 | Feb 2005 | WO |
WO2005087140 | Sep 2005 | WO |
WO2006041877 | Apr 2006 | WO |
WO2006063199 | Jun 2006 | WO |
WO2007008371 | Jan 2007 | WO |
WO2007067820 | Jun 2007 | WO |
WO2007098232 | Aug 2007 | WO |
2007129125 | Nov 2007 | WO |
WO2008022077 | Feb 2008 | WO |
WO2008028569 | Mar 2008 | WO |
WO2008035337 | Mar 2008 | WO |
WO2008103497 | Aug 2008 | WO |
WO2008103722 | Aug 2008 | WO |
WO2008129405 | Oct 2008 | WO |
WO2009045338 | Apr 2009 | WO |
WO2009091509 | Jul 2009 | WO |
WO2010006627 | Jan 2010 | WO |
WO2010008549 | Jan 2010 | WO |
WO2010057262 | May 2010 | WO |
WO2010080594 | Jul 2010 | WO |
WO2010098857 | Sep 2010 | WO |
WO2010099032 | Sep 2010 | WO |
WO2010117680 | Oct 2010 | WO |
WO2010121076 | Oct 2010 | WO |
WO2011025981 | Mar 2011 | WO |
WO2011034973 | Mar 2011 | WO |
WO2011047168 | Apr 2011 | WO |
WO2011051043 | May 2011 | WO |
WO2011057087 | May 2011 | WO |
WO2011072084 | Jun 2011 | WO |
WO2011106137 | Sep 2011 | WO |
WO2011106544 | Sep 2011 | WO |
WO2011111047 | Sep 2011 | WO |
WO2011137531 | Nov 2011 | WO |
WO2011139747 | Nov 2011 | WO |
WO2012011018 | Jan 2012 | WO |
WO2012011108 | Jan 2012 | WO |
WO2012027487 | Mar 2012 | WO |
WO2012035279 | Mar 2012 | WO |
WO2012040655 | Mar 2012 | WO |
WO2012047644 | Apr 2012 | WO |
WO2012052718 | Apr 2012 | WO |
WO2012055498 | May 2012 | WO |
WO2012087842 | Jun 2012 | WO |
WO2012095455 | Jul 2012 | WO |
WO2012102928 | Aug 2012 | WO |
WO2012106602 | Aug 2012 | WO |
WO2012118508 | Sep 2012 | WO |
WO2012118816 | Sep 2012 | WO |
WO2012118894 | Sep 2012 | WO |
WO2012177942 | Dec 2012 | WO |
WO2013021374 | Feb 2013 | WO |
WO2013021375 | Feb 2013 | WO |
WO2013028387 | Feb 2013 | WO |
WO2013059743 | Apr 2013 | WO |
WO2013059747 | Apr 2013 | WO |
WO2013114214 | Aug 2013 | WO |
WO2013120181 | Aug 2013 | WO |
WO2013123059 | Aug 2013 | WO |
WO2013128432 | Sep 2013 | WO |
WO2013130641 | Sep 2013 | WO |
WO2013131925 | Sep 2013 | WO |
WO2013140318 | Sep 2013 | WO |
WO2013148017 | Oct 2013 | WO |
WO2013148018 | Oct 2013 | WO |
WO2013148019 | Oct 2013 | WO |
WO2013150512 | Oct 2013 | WO |
WO2013152161 | Oct 2013 | WO |
WO2013158613 | Oct 2013 | WO |
WO2013169448 | Nov 2013 | WO |
WO2013175468 | Nov 2013 | WO |
WO2013176583 | Nov 2013 | WO |
WO2013188077 | Dec 2013 | WO |
WO2013192107 | Dec 2013 | WO |
2014039392 | Mar 2014 | WO |
WO2014036113 | Mar 2014 | WO |
WO2014043527 | Mar 2014 | WO |
WO2014047111 | Mar 2014 | WO |
WO2014047325 | Mar 2014 | WO |
WO2014055981 | Apr 2014 | WO |
WO2014059432 | Apr 2014 | WO |
WO2014064694 | May 2014 | WO |
WO2014066365 | May 2014 | WO |
WO2014089424 | Jun 2014 | WO |
WO2014093861 | Jun 2014 | WO |
WO2014111918 | Jul 2014 | WO |
WO2014114794 | Jul 2014 | WO |
WO2014114795 | Jul 2014 | WO |
WO2014114796 | Jul 2014 | WO |
WO2014114798 | Jul 2014 | WO |
WO2014116502 | Jul 2014 | WO |
WO2014121280 | Aug 2014 | WO |
WO2014128705 | Aug 2014 | WO |
WO2014134277 | Sep 2014 | WO |
WO2014138194 | Sep 2014 | WO |
WO2014138284 | Sep 2014 | WO |
WO2014138482 | Sep 2014 | WO |
WO2014138868 | Sep 2014 | WO |
WO2014144100 | Sep 2014 | WO |
WO2014144937 | Sep 2014 | WO |
WO2014145338 | Sep 2014 | WO |
WO2014147336 | Sep 2014 | WO |
WO2014152306 | Sep 2014 | WO |
WO2014152375 | Sep 2014 | WO |
WO2014152503 | Sep 2014 | WO |
WO2014153544 | Sep 2014 | WO |
WO2014158617 | Oct 2014 | WO |
WO2014162181 | Oct 2014 | WO |
WO2014162306 | Oct 2014 | WO |
WO2014163705 | Oct 2014 | WO |
WO2014168655 | Oct 2014 | WO |
WO2014179391 | Nov 2014 | WO |
WO2014181336 | Nov 2014 | WO |
WO2014189974 | Nov 2014 | WO |
WO2014191994 | Dec 2014 | WO |
WO2014194178 | Dec 2014 | WO |
WO2014201384 | Dec 2014 | WO |
WO2014201452 | Dec 2014 | WO |
WO2014205064 | Dec 2014 | WO |
WO2014207699 | Dec 2014 | WO |
WO2014210124 | Dec 2014 | WO |
WO2014210299 | Dec 2014 | WO |
WO2015009503 | Jan 2015 | WO |
WO2015020971 | Feb 2015 | WO |
WO2015028986 | Mar 2015 | WO |
WO2015051430 | Apr 2015 | WO |
WO2015052663 | Apr 2015 | WO |
WO2015057407 | Apr 2015 | WO |
WO2015057735 | Apr 2015 | WO |
WO2015057995 | Apr 2015 | WO |
WO2015061378 | Apr 2015 | WO |
WO2015061431 | Apr 2015 | WO |
WO2015061463 | Apr 2015 | WO |
WO2015061533 | Apr 2015 | WO |
WO2015075128 | May 2015 | WO |
WO2015081775 | Jun 2015 | WO |
WO2015089334 | Jun 2015 | WO |
WO2015092554 | Jun 2015 | WO |
WO2015120122 | Aug 2015 | WO |
WO2015125024 | Aug 2015 | WO |
WO2015127264 | Aug 2015 | WO |
WO2015127283 | Aug 2015 | WO |
WO2015191604 | Aug 2015 | WO |
WO2015191839 | Aug 2015 | WO |
WO2015195823 | Aug 2015 | WO |
WO2016011185 | Aug 2015 | WO |
WO2015128739 | Sep 2015 | WO |
WO2015128741 | Sep 2015 | WO |
WO2015128747 | Sep 2015 | WO |
WO2015132667 | Sep 2015 | WO |
WO2015132668 | Sep 2015 | WO |
WO2015135050 | Sep 2015 | WO |
WO2015142648 | Sep 2015 | WO |
WO2015142834 | Sep 2015 | WO |
WO2016020918 | Sep 2015 | WO |
WO2016027272 | Sep 2015 | WO |
WO2016059533 | Sep 2015 | WO |
WO2016065158 | Sep 2015 | WO |
WO2016073741 | Sep 2015 | WO |
WO2016083551 | Sep 2015 | WO |
WO2016093877 | Sep 2015 | WO |
WO2015148241 | Oct 2015 | WO |
WO2015171190 | Nov 2015 | WO |
WO2015171743 | Nov 2015 | WO |
WO2015179181 | Nov 2015 | WO |
WO2016097337 | Jun 2016 | WO |
WO2016108181 | Jul 2016 | WO |
WO2016133950 | Aug 2016 | WO |
2016154168 | Sep 2016 | WO |
WO2016150806 | Sep 2016 | WO |
WO2016201024 | Dec 2016 | WO |
WO2016209970 | Dec 2016 | WO |
WO2017011697 | Jan 2017 | WO |
WO2017062640 | Apr 2017 | WO |
WO2017096157 | Jun 2017 | WO |
WO2017101232 | Jun 2017 | WO |
WO2017117388 | Jul 2017 | WO |
WO2017127939 | Aug 2017 | WO |
WO2017136596 | Aug 2017 | WO |
WO2017196511 | Nov 2017 | WO |
WO2017196909 | Nov 2017 | WO |
WO2017196977 | Nov 2017 | WO |
WO2017197064 | Nov 2017 | WO |
WO2017218671 | Dec 2017 | WO |
WO2018017886 | Jan 2018 | WO |
WO2018029680 | Feb 2018 | WO |
Entry |
---|
US 9,265,606 B2, 02/2016, Buchbinder et al. (withdrawn) |
Communication Pursuant to Article 94(3) EPC in European Application No. 16 757 502.6, dated Nov. 30, 2021. |
Notice of Reasons for Rejection in Japanese Application No. 2018-509843, dated Jan. 5, 2022. |
Bernard et al., “Aortic Valve Area Evolution After Percutaneous Aortic Valvuloplasty,” European Heart Journal, Jul. 1990, vol. 11 (2), pp. 98-107. |
BlueCross BlueShield of Northern Carolina Corporate Medical Policy “Balloon valvuloplasty, Percutaneous”, (Jun. 1994). |
Cimino et al., “Physics of Ultrasonic Surgery Using Tissue Fragmentation: Part I and Part II”, Ultrasound in Medicine and Biologyl, Jun. 1996, vol. 22 (1), pp. 89-100, and pp. 101-117. |
Cimino, “Ultrasonic Surgery: Power Quantification and Efficiency Optimization”, Aesthetic Surgery Journal, Feb. 2001, pp. 233-241. |
Cowell et al., “A Randomized Trial of Intensive Lipid-Lowering Therapy in Calcific Aortic Stenosis,” NEJM, Jun. 2005, vol. 352 (23), pp. 2389-2397. |
De Korte et al., “Characterization of Plaque Components and Vulnerability with Intravascular Ultrasound Elastography”, Phys. Med. Biol., Feb. 2000, vol. 45, pp. 1465-1475. |
European Search Report dated Mar. 13, 2015 for European Application. No. 05853460.3. |
Feldman, “Restenosis Following Successful Balloon Valvuloplasty: Bone Formation in Aortic Valve Leaflets”, Cathet Cardiovasc Diagn, May 1993, vol. 29 (1), pp. 1-7. |
Fitzgerald et al., “Intravascular Sonotherapy Decreased Neointimal Hyperplasia After Stent Implantation in Swine”, Circulation, Feb. 2001, vol. 103, pp. 1828-1831. |
Freeman et al., “Ultrasonic Aortic Valve Decalcification: Serial Doppler Echocardiographic Follow Up”, J Am Coll Cardiol., Sep. 1990, vol. 16 (3), pp. 623-630. |
Greenleaf et al., “Selected Methods for Imaging Elastic Properties of Biological Tissues”, Annu. Rev. Biomed. Eng., Apr. 2003, vol. 5, pp. 57-78. |
Gunn et al., “New Developments in Therapeutic Ultrasound-Assisted Coronary Angioplasty”, Curr Interv Cardiol Rep., Dec. 1990, vol. 1 (4), pp. 281-290. |
Guzman et al., “Bioeffects Caused by Changes in Acoustic Cavitation Bubble Density and Cell Concentration: A Unified Explanation Based on Cell-to-Bubble Ratio and Blast Radius”, Ultrasound in Med. & Biol., Mar. 2003, vol. 29 (8), pp. 1211-1222. |
Hallgrimsson et al., “Chronic Non-Rheumatic Aortic Valvular Disease: a Population Study Based on Autopsies”, J Chronic Dis., Jun. 1979, vol. 32 (5), pp. 355-363. |
Isner et al., “Contrasting Histoarchitecture of Calcified Leaflets from Stenotic Bicuspid Versus Stenotic Tricuspid Aortic Valves”, J Am Coll Cardiol., Apr. 1990, vol. 15 (5), p. 1104-1108. |
Lung et al., “A Prospective Survey of Patients with Valvular Heart Disease in Europe: The Euro Heart Survey on Valvular Heart Disease”, Euro Heart Journal, Mar. 2003, vol. 24, pp. 1231-1243. |
McBride et al “Aortic Valve Decalcification”, J Thorac Cardiovas-Surg, Jul. 1990, vol. 100, pp. 36-42. |
Miller et al., “Lysis and Sonoporation of Epidermoid and Phagocytic Monolayer Cells by Diagnostic Ultrasound Activation of Contrast Agent Gas Bodies”, Ultrasound in Med. & Biol., May 2007, vol. 27 (8), pp. 1107-1113. |
Mohler, “Mechanisms of Aortic Valve Calcificaion”, Am J Cardiol, Dec. 2004, vol. 94 (11), pp. 1396-1402. |
Otto et al., “Three-Year Outcome After Balloon Aortic Valvuloplasty. Insights into Prognosis of Valvular Aortic Stenosis”, Circulation, Feb. 1994, vol. 89, pp. 642-650. |
Passik et al., “Temporal Changes in the Causes of Aortic Stenosis: A Surgical Pathologic Study of 646 Cases”, Mayo Clin Proc, Feb. 1987, vol. 62, pp. 19-123. |
Quaden et al., “Percutaneous Aortic Valve Replacement: Resection Before Implantation”, Eur J Cardiothorac Surg, Jan. 2005, vol. 27, pp. 836-840. |
Riebman et al., “New Concepts in the Management of Patients with Aortic Valve Disease”, Abstract, Valvular Heart Disease, JACC, Mar. 2004, p. 34A. |
Rosenschein et al., “Percutaneous Transluminal Therapy of Occluded Saphenous Vein Grafts” Circulation, Jan. 1999, vol. 99, pp. 26-29. |
Sakata et al., “Percutaneous Balloon Aortic Valvuloplasty: Antegrade Transseptal vs. Conventional Retrograde Transarterial Approach”, Catheter Cardiovasc Interv., Mar. 2005, vol. 64 (3), pp. 314-321. |
Sasaki et al., “Scanning Electron Microscopy and Fourier Transformed Infrared Spectroscopy Analysis of Bone Removal Using Er:YAG and CO2 Lasers”, J Periodontol., Jun. 2002, vol. 73 (6), pp. 643-652. |
Search Report and Written Opinion dated Dec. 10, 2012 for PCT Application No. PCT/US2012/043636. |
Search Report and Written Opinion dated Dec. 6, 2016 for PCT Application No. PCT/US2016/047831. |
International Search Report and Written Opinion dated Apr. 19, 2014 PCT Application No. PCT/US2012/061215. |
International Search Report and Written Opinion dated Apr. 19, 2014 PCT Application No. PCT/US2012/061219. |
International Search Report and Written Opinion dated Jul. 11, 2018 for PCT Application No. PCT/US2018/027990, 15 pages. |
International Search Report and Written Opinion dated Jun. 28, 2018 for PCT Application No. PCT/US2018/027983, 15 pages. |
International Search Report and Written Opinion dated Aug. 3, 2018 for PCT Application No. PCT/US2018/035086, 15 pages. |
International Search Report and Written Opinion dated Aug. 9, 2018 for PCT Application No. PCT/US2018/035081, 11 pages. |
Search Report and Written Opinion dated Mar. 2, 2015 for PCT Application No. PCT/US2014/029549. |
Search Report and Written Opinion dated May 1, 2012 for PCT Application No. PCT/US2011/065627. |
Search Report and Written Opinion dated May 22, 2007 for PCT Application No. PCT/US2005/044543. |
Search Report and Written Opinion dated Oct. 20, 2014 for PCT Application No. PCT/US2014/038849. |
Search Report and Written Opinion dated Sep. 4, 2014 for PCT Application No. PCT/US2014/014704. |
The Core Valve System Medtronic, 2012, 4 Pages. |
Van Den Brand et al., “Histological Changes in the Aortic Valve after Balloon Dilation: Evidence for a Delayed Healing Process”, Br Heart J, Jun. 1992, vol. 67, pp. 445-459. |
Verdaasdonk et al., “The Mechanism of Action of the Ultrasonic Tissue Resectors Disclosed Using High-Speed and Thermal Imaging Techniques”, SPIE, Jan. 1999, vol. 3594, pp. 221-231. |
Voelker et al., “Inoperative Valvuloplasty in Calcific Aortic Stenosis: a Study Comparing the Mechanism of a Novel Expandable Device with Conventional Balloon Dilation”, Am Heart J., Nov. 1991, vol. 122 (5), pp. 1327-1333. |
Waller et al., “Catheter Balloon Valvuloplasty of Stenotic Aortic Valves. Part II: Balloon Valvuloplasty During Life Subsequent Tissue Examination”, Clin Cardiol., Nov. 1991, vol. 14 (11), pp. 924-930. |
Wang, “Balloon Aortic Valvuloplasty”, Prog Cardiovasc Dis., Jul.-Aug. 1997, vol. 40 (1), pp. 27-36. |
Wilson et al., “Elastography—The movement Begins”, Phys. Med. Biol., Jun. 2000, vol. 45, pp. 1409-1421. |
Yock et al., “Catheter-Based Ultrasound Thrombolysis”, Circulation, Mar. 1997, vol. 95 (6), pp. 1411-1416. |
Prosecution History from U.S. Appl. No. 15/241,155, dated May 16, 2018 through Feb. 5, 2019, 51 pp. |
International Preliminary Report on Patentability from International Application No. PCT/US2016/047831, dated Feb. 27, 2018, 8 pp. |
Communication Pursuant to Rules 161(1) and 162 EPC dated May 7, 2018, from counterpart European Application No. 16757502.6, 3 pp. |
Response to Communication pursuant to Rules 161(1) and 162 EPC dated May 7, 2018, from counterpart European Application No. 16757502.6, filed Nov. 16, 2018, 26 pp. |
Notice of First Office Action, CN Application No. 202010483590.3, dated Sep. 7, 2022. |
Number | Date | Country | |
---|---|---|---|
20210113329 A1 | Apr 2021 | US |
Number | Date | Country | |
---|---|---|---|
62208458 | Aug 2015 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 16273065 | Feb 2019 | US |
Child | 17087530 | US | |
Parent | 15241155 | Aug 2016 | US |
Child | 16273065 | US |